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Identification of Key Structural Elements of ATP-Dependent Molecular Motors 
Yuan Zhang 
Molecular motors perform diverse functions in cells, ranging from muscle 
contraction, cell division, DNA/RNA replication, protein degradation, and vesicle 
transport. The majority of molecular motors use energy from the ATP hydrolysis cycle, 
converting chemical energy into mechanical work in cells. All ATP-dependent molecular 
motors have a similar ATP binding site, although the functions can be drastically 
different. 
 
Myosins comprise a large group of ATP-dependent molecule motors. The 
structure-function relationship governing different functions for different myosin families 
remains elusive. Hypothesizing that members of each family possess conserved residues 
for their consensus functions and residues distinctive from those of other families to 
differentiate their functions from functions of other myosin families, we developed an 
algorithm for comparative sequence analysis in a phylogenic hierarchy to identify 
family-specific residues for 38 myosin families/subfamilies that comprise human myosin 
members. We found a number of family-specific residues that have been reported, such as 
residues in β-cardiac myosin associated with hypertrophic cardiomyopathy and residues 
in myosin 7A associated with hereditary deafness. We also identified distinct features 





SH1 domain in each of the myosin families, residues differentiating α- and β-cardiac 
myosins, and a unique converter domain of myosin VI. 
 
We further examined myosin VI to understand why it moves toward the (-)-end of 
actin filaments, opposite to the direction of all other myosins and to shed light on their 
links to prostate cancer and ovarian cancer, where myosin VI is over-expressed. We 
found that many of myosin VI specific residues locate in or adjacent to the converter 
domain, including a cluster of unique residues at the interface between the motor domain 
and the converter. Using molecular dynamics (MD) simulation, we found mutations of 
M701 on the SH1 helix and F763 on a helix of the converter caused the separation of the 
motor domain and the converter, indicating their important roles in linking the converter 
and the motor domain in the pre-power stroke state structure, potentially critical for 
positioning of lever arm. Using the location of the unique residues at the interface of the 
motor domain and the converter as the site of drug docking, we identified a set of 
candidate small molecules binding to this unique binding site selectively, potentially 
blocking the converter rotation of myosin VI. A benzoic acid (C15H17N3O3) was found 
to have the best score in docking, binding to both the converter and motor domain stably 
in a 200 ns MD simulation run. This molecule can be a good lead to be optimized to 






We have also applied our algorithm to other ATP-dependent molecular motors, 
including hepatitis C virus NS3 helicase and DEAD box helicase Mss116. We found an 
important residue, T324, in NS3 helicase connecting domains 1 and 2 acting as a flexible 
hinge for opening of the ATP-binding cleft and an atomic interaction cascade from T324 
to residues in domains 1 and 2 controls the flexibility of the ATP-binding cleft in NS3 
helicase. We also found a conserved flexible linker for Mss116, and the tight interactions 
between the Mss116-specific flexible linker and the two RecA-like domains are 
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1. Background and Motivation 
1.1  Significance of molecular motors 
Molecular motors are biological machines responsible for diverse functions in our 
living cells. They harness the chemical free energy of the ATP hydrolysis cycle to 
perform mechanical work. In terms of energy efficiency, this type of motor is much better 
comparing to currently available man-made motors. In terms of functions, molecule 
motors are involved in muscle contraction[1], cell division[2-3], ciliary functions[4-5] 
and DNA/RNA transcription/replication[6-7]. They are also related to diseases such as 
hypertrophic cardiomyopathy (HCM)[8-10], polycystic kidney disease[11], 
neurodegeneration[12-14] and cancers[15]. 
 
Three types of cytoplasmic molecular motors are known: myosins, which move on 
actin filaments, and dyneins and kinesins, which use microtubules as their tracks. These 
three types of motors are associated with important cellular functions: myosin is 
responsible for contraction and movement, dynein with ciliary beating, and kinesin with 
organelle transport. In addition, functions such as signaling, RNA localization and 
sensory transduction are also related to these three motors. Helicase is another example of 
molecule motors which is involved in almost all aspects of nucleic acid metabolism 







1.2  Myosin is a large group of ATP-dependent molecular motors 
Myosins are ATP-dependent molecular motors expressed in eukaryotic cells and 
important for a broad range of cellular functions like muscle contraction, vision, hearing, 
cell motility etc [16-18]. Myosin heavy chains consist of distinct head, neck, and tail 
domains and have previously been categorized into 18 different classes based on 
phylogenetic analysis of their conserved heads [19-20]. In 2005, TA Richards et al found 
37 different protein domain combinations based on 150 myosin sequences from 20 
different species [18] and in 2006 BJ Foth et al conducted a comprehensive phylogenetic 
examination of many previously unclassified myosins and six novel myosin classes are 
established [21]. In 2007 F Odronitz et al reconstructed the phylogenetic tree of 
eukaryotic life based on the analysis of 2,269 myosin motor domains from 328 organisms. 
They also aligned and grouped these myosin sequences into 35 myosin classes [22]. Their 
analysis of the myosin classification is a combination of phylogenetic information 
derived from class-specific trees and the information of myosin class evolution and 
distribution. 
 
There are several well established myosin sequences alignments. In 2000, T Hodge et 
al created an alignment of 139 members of the myosin superfamily [19]. The alignment 





performed with the Clustal-W package [23]. In other studies of myosin classification 
people created several alignments of myosin in order to plot a phylogenetic tree, however 
most of them are limited to the number of sequences involved. In 2007 F Odronitz et al 
created the alignment of 1984 myosin sequences from 328 species [22]. They manually 
annotated the sequence alignment and corrected problems within automatic gene 
annotation process. And their alignment is believed to be the most accurate and complete 
myosin alignment so far and our sequence analysis in this paper is based on this 
alignment. 
 
Myosins are constructed of three functional domains: (1) the motor domain which 
interacts with actin and binds ATP, (2) the neck domain which binds light chains or 
calmodulin, and (3) the tail domain anchoring and positioning the motor domain. The 
motor domains are relatively conserved among all myosin families which consist of the 
N-terminal, lower 50K domain, upper 50K domain, and the converter. Within the head 
domain, several strictly conserved regions have been identified, including P-loop, Switch 
I and Switch II, forming the ATP binding pocket [24-25]. These strictly conserved motifs 
show that myosins share a similar ATP binding mechanism. Loop 2, loop 4, the 
cardiomyopathy loop, helix-turn-helix and loop 3 locate at the actin binding site. These 
subdomains vary significantly among myosin families, potentially responsible for 





SH1-SH2 helices and the converter domain form the force-generating region and are 
involved in communication between the ATP binding site and the lever arm [26]. The 
N-terminus of the relay helix is a continuation of switch II, while its C-terminus interacts 
with the converter through a number of hydrophobic residues. The converter is 
sequentially followed by the lever arm, delivering the mechanical work through power 
strokes. 
 
1.3  NS3 helicase 
Hepatitis C virus (HCV) is the major agent of parentally transmitted non-A and non-B 
hepatitis [27], causing chronic hepatitis, liver cirrhosis and hepatocellular carcinoma 
[27-28]. About 3% of the worldwide population is infected by HCV and currently no 
protective vaccine is available. Recent research efforts have targeted the replicative 
enzymes of HCV as potential and important therapeutic targets in drug design [29]. A 
variety of ATP binding inhibitors are under development to block the HCV replication, 
including ones which have already been used as successful therapeutic agents for chronic 
myeloid leukemia and other serious diseases [30]. Even though these findings suggest 
feasible strategies for developing specific inhibitors to block the action of this critical drug 
target, an accurate description of protein flexibility and its influence on ATP recognition is 
unavailable. In the past decade, a lot of advancement has been made to incorporate protein 





conformational states and that a ligand may bind preferentially to particular available 
conformations [31-37]. Even though many promising methods have been introduced to aid 
a more accurate description of protein flexibility in ligand binding, there is still a great need 
for more effective research to understand the ensembles of HCV protein structures 
representing global and local flexibility. 
 
The HCV genome encodes a large poly-protein called nonstructural protein 3 (NS3), 
which is responsible for viral replication. NS3 is classified as a superfamily-2 (SF2) 
helicase, which has polynucleotide triggered dNTPase activity and can unwind both RNA 
and DNA in the 3'-5' direction [38]. It is composed of three domains, domains 1 and 2 with 
conserved RecA-like motifs able to sandwich ATP [39]; and the polynucleotide resides 
orthogonally in a groove between domain 3 and domains 1 and 2 [40]. The residues that are 
conserved among SF2 helicases dominantly reside in the inter-domain cleft of domains 1 
and 2. Motif I or Walker A motif is highly conserved and responsible for the ATP binding 
and catalysis, motif II or Walker B motif is responsible for catalytic water positioning and 
Mg
2+
 coordination, while motif VI contains the conserved arginine finger from domain 2 
critical for catalysis. ATP can form an extensive hydrogen bond network [41], and its 
binding to the catalytic site and its hydrolysis cycle are tightly coupled to the 





been proposed and examined [42-43], although the atomic details of how the ATPase cycle 
can regulate the conformational changes remain unclear. 
 
Previous single-molecule fluorescence resonance energy transfer (FRET) experiments 
revealed that the HCV NS3 helicase duplex unwinding characteristics include periodic 
pauses of the helicase during this process [44]. Another study demonstrated that upon ATP 
binding, the enzyme undergoes a conformational change resulting in an almost 100% 
decrease in the association rate constant for the enzyme and nucleic acid [45]. Several 
crystal structures of NS3 helicases showed that the helicase domain was complexed with a 
single-stranded DNA [46]. Based on these protein structures, a model was proposed 
detailing the molecular mechanism of single-stranded polynucleotide translocation. These 
findings revealed that ATP binding induced closure between RecA-like domains 1 and 2, 
which resulted in an associated unidirectional movement of the bound polynucleotide 
relative to the protein. This model was supported by an inchworm mechanism proposed 
subsequently for HCV NS3 helicase, which extended the previous hypothesis with an 
additional mechanism responsible for duplex unwinding tightly coupled to the DNA 
translocation process [47]. A comparative structural study [48] between HCV NS3 helicase 
and Rep helicase, an SF1 family member, demonstrated the importance of motif III 
(322-326), which contains amino acid residue T324, in the indirect transduction of 






 To gain a better understanding of the underlying atomic details of this model, ATPase 
activities of a series of helicase mutants were measured in the presence of poly(U) to 
simulate the ATP hydrolysis of HCV NS3 [49]. Enzymatic activity was measured 
kinetically by varying the concentration of the ATP substrate. Compared to the wild-type 
protein all mutants showed a reduced level of ATPase activity [49]. One of the two mutated 
threonine residues was T324, which is thought to act as a hinge connecting domains 1 and 
2 of the ATP binding cleft. When substituting alanine for T324 or T322, ATPase activity 
was dramatically reduced to 30% and 16% compared to the wild-type protein respectively. 
These results revealed the importance of hinge residue T324 of motif III in ATPase activity 
regulation due to its vital role in modulating the opening and closing of the ATP binding 
cleft between the two domains. Thus, the detailed understanding of the opening/closing of 
domains 1 and 2 associated with the ATP binding mechanism on the atomic level provides 
a promising approach for new therapeutic options, targeting the ATP binding site for 
potential hepatitis C treatment. 
 
Recently a set of crystal structures of NS3 helicase were obtained [50], in which ATP 
mimics (ADP · BeF3 and ADP · AlF4
-
) were captured in the ground and transition states. 
The results indicated that NS3 domains 1 and 2 close in the presence of ADP · AlF4
-
, which 





including D290, E291, Q460, T212 and K210, which reside prominently in the 
interdomain cleft, play a critical role in active-site rearrangement to stabilize the ATP 
moiety for catalysis [50]. These interdomain residues were examined by in vitro kinetic 
experiments of mutant NS3 helicases [49], and the results revealed that K210 in the Walker 
A nucleotide binding motif and D290, E291 in the Walker B motif were crucial to ATPase 
activity, while Q460 acted as a gatekeeper playing an essential role influencing the 
microenvironment modulating enzymatic activities in that region. It was also shown that 
T212 plays a role in stabilizing the ATP interaction for catalysis based on conformational 
snapshots of NS3 helicase [50]. 
 
1.4  DEAD box protein Mss116 
DEAD-box proteins are a ubiquitous family of ATP-dependent RNA helicases that 
function in various cellular processes including gene transcription, RNA splicing, 
ribosome biogenesis, RNA transport, translation initiation, mitochondrial gene expression 
and mRNA degradation [51]. They are the members of the helicase superfamily II (SF II) 
and are composed of a helicase core consisting of two RecA-like domains (domains 1 and 
2) connected by a short flexible linker [52]. The helicase core contains several conserved 
motifs (along with motif II: D-E-A-D) that are required for helicase activities, such as 
ATP or RNA binding, as well as interdomain interactions. Although these motifs are 





C-terminal extensions, which can widely differ among different protein species and often 
target the proteins to specific substrates [51, 53]. Previous studies of DEAD-box proteins 
demonstrated that the two flexibly attached core domains stabilize in closed conformation 
upon cooperative ATP and RNA binding [54-55].  
 
DEAD-box protein Mss116 from Saccharomyces cerevisiae is a mitochondrial RNA 
helicase that functions in mitochondrial group I and group II intron splicing, translational 
activation, and RNA end processing [56]. As general RNA chaperones, Mss116 bind 
RNA substrates nonspecifically and rearrange rate-limiting structures for RNA folding 
[57]. Several studies of Mss116 helicase illuminated the general mechanism of 
DEAD-box proteins as RNA chaperones on psychological substrates [57-60]. In Mss116, 
a short N-terminal (NTE) and an α-helical C-terminal extension (CTE) flank the helicase 
core region with a basic tail following the CTE [60]. The helicase core of Mss116 is very 
similar to those of other DEAD-box proteins and plays a major role in RNA crimping 
associated with the strand separation mechanism. Based on high-throughput genetic 
studies, it was shown that the NTE contributes minimally to Mss116 function in vivo [61]. 
On the other hand, the truncation or mutations within the CTE of Mss116 have shown to 
inactivate RNA-dependent ATPase activity and decrease RNA-binding affinity, implying 
that this region may contribute to the stability of the helicase core and RNA binding [60]. 





and group I and group II intron splicing activity, while having little effect on 
RNA-dependent ATPase activity [60, 62]. It has been proposed that the basic tail interacts 
with the bound RNA primarily via non-specific electrostatic interactions, thereby 
potentially governing the RNA binding and RNA-unwinding activities [60]. 
 
Mutational and structural studies have revealed the roles for many conserved motifs 
in DEAD-box helicase Mss116: (1) motifs Q, I and II of domain 1 bind ATP and are 
required for its hydrolysis; (2) motif III of domain 1 links ATP binding and hydrolysis to 
conformational changes required for helicase activity; (3) motif VI of domain 2 
participates in ATP binding; and (4) motifs GG, QxxR, Ia, Ib, IV, and V are possibly 
involved in RNA binding [63]. Additionally, studies based on a structure of Mss116 with 
C-terminal truncations bound to RNA oligonucleotide U10 and ATP analog AMP-PNP 
(mimicking ground state) showed that it acts as a molecular crimper by producing two 
bends on the bound single-stranded RNA [64]. This suggests that although other 
DEAD-box proteins such as Vasa, elF4AIII and DDX19 may accomplish RNA 
unwinding by inducing only one bend, it is also possible, as shown by this Mss116 
structure, that DEAD-box proteins accomplish unwinding by producing two bends [64]. 
A recent work identified the functions of two RecA-like domains of Mss116 and the 
cooperation of these two domains in recognizing and unwinding RNA duplexes [65]. 





II intron splicing, translational activation and RNA end processing makes Mss116 an 
important model system for studying DEAD-box protein functions. 
 
1.5  Bioinformatics and computational biophysics on the studies of molecular 
motors 
Sequence analysis serves as an important tool to understand the structure-function 
relationship of proteins and plays an important role in protein structure prediction. For 
example, S Tang et al predicted allosteric communication in myosin using conservation 
analysis [26]. Sequence analysis is also a powerful tool in identifying functionally 
important residues for a specific myosin family. There are abundant sequence analysis 
methods in scoring residue conservation. The evolutionary trace method was first 
described in 1996 by O Lichtarge and has had been applied to a variety of studies [66]. 
Quality score in Clustal is also a convenient way to obtain a residue conservation quality 
[23]. In 2002, SJ Valdar surveyed a range of scoring approaches that biologists, 
biochemists, and, more recently, bioinformatics workers have developed and discussed 
the advantage and intrinsic problems associated with each method [67]. 
 
MD simulation is another computational approach to reveal conformational 
equilibrium and dynamics in atomic details. It has been applied widely in understanding 





[68-71]. In a MD simulation, Newton's equations of motion for the system are integrated 
numerically and the forces between two atoms are approximated by a Lennard-Jones 
potential energy function. We have used MD simulation to design our engineered myosin 
VI constructs in our previous study [72]. Virtual screening is a computational technique 
used in drug discovery research [73]. It searches large libraries of small molecules in 
order to identify structures that bind tightly to a target site.  
 
1.6  Outline of this work 
After briefly sketching out the background about the topics of interest in this work in 
Chapter 1, Chapter 2 will cover the details the bioinformatics studies of the myosin 
superfamily. We will describe the sequence analysis algorithm we developed to identify 
residues that are conserved within a group of proteins but distinct when compared with 
the amino acids of the same alignment location of other proteins. Further, we will discuss 
the results of sequence comparisons between myosin families using our algorithm and the 
structural analysis of family-specific residues. 
 
In Chapter 3, we will focus on myosin VI, the only known myosin walking toward 
the (-) end of actin filament. We will discover the relationship between myosin VI 





the important roles of myosin VI specific residues. Virtual screening will be used to 
identify potential small molecules blocking myosin VI’s converter rotation. 
 
In Chapters 4 and 5, we will apply computational biology methods studying two 
additional examples of molecular motors: NS3 helicase and DEAD box Mss116. NS3 
helicase is responsible for the viral replication for HCV. Understanding the regulation 
mechanism of ATP binding will facilitate targeting of the ATP binding site for potential 
therapeutic development for hepatitis C. In Chapter 4, we will examine the hinge 
connecting domains 1 and 2 of NS3 helicase to understand the mechanism of the opening 
of the ATP binding cleft. We will use MD simulation to examine the mutational effects of 
T324, the hinge residue, on the dynamics of the ATP binding site. 
 
DEAD-box RNA helicases are ATP-dependent proteins implicated in nearly all 
aspects of RNA metabolism. The yeast DEAD-box helicase Mss116 is unique in its 
functions of splicing group I and group II introns and activating mRNA translation, but 
the structural understanding of why it performs these unique functions remain unclear. In 
Chapter 5, we will use sequence analysis to identify residues that are conserved among 
Mss116 proteins and unique when compared to other RNA helicases. MD simulation will 
focus on mutations in the flexible linker region of Mss116 aiming to reveal residues 






In Chapter 6, we will briefly summarize our results. This work demonstrates our 
novel findings in integrating sequence analysis, structural analysis, and MD simulation to 
reveal the structure-function relationships of a variety of ATP-dependent molecule 
motors. 
 
2. Bioinformatics study of myosin families 
2.1  Development of conservation and uniqueness method 
We developed a proprietary conservation and uniqueness algorithm to identify family 
specific residues that are not only evolutionary important for the family but also distinct 
from the amino acids at the same alignment locations of other families. 
 
For example, in the sequence comparison between myosin I and all other myosin 
sequences, all the residues in myosin I would first receive a conservation score and then a 
uniqueness score. The conservation score was obtained by calculating a weighted value 
based on the percentage of amino acids that are identical among all myosin I sequences. 
If all sequences shared the same amino acid in one column, this residue in myosin I 
sequence in this column would receive a conservation score of 1 (100%). We developed a 





                               
            
   
                         E2.1 
where w(i) is the percentage of the appearance of each amino acid in a single column 
within the myosin I family. Note that e-1 in the denominator is the normalizing factor 
such that when all sequences shared the same amino acid, MAX(w(i))=1, and the 
conservation score would be 1. Higher the conservation score means more conserved of 
the residue in an alignment column. The exponential formula was used in order to 
magnify the effects of high conservation. For example, the score difference between 
cases of 100% and 99% conserved is larger than the difference between cases of 99% and 
98% conserved.  
 
We developed a weighted uniqueness scoring method to study how much amino 
acids in a single family differ from those of all other myosin families. Here we again use 
myosin I as an example. For the uniqueness score of a single column, we developed the 
following equation: 
                              
                    
   
                   E2.2 
where i represents 20 different types of amino acids ranging from A to Y, w(i) is the 
percentage of the appearance of i-th amino acid in a single column within the myosin I 
family, p(i) is the percentage of myosin sequences other than those of the myosin I family 
possessing the i-th amino acid in the same alignment column. Higher the uniqueness 





other myosin families. The percentage of gaps was also recorded for each column, and 
the penalty was applied to the final score for gaps. 
 
The final score of each column was calculated by adding the conservation and 
uniqueness scores, and then subtracting the penalty score of gaps. We ranked all columns 
and found the residues with the top scores. We mapped these columns to the human 
myosin I sequence and created a list of myosin I family-specific residues.  
 
2.2  Structure modeling of human myosins 
To locate family-specific residues in structures of human myosins, we 
computationally built structures for each human myosin by performing homology 
modeling. BLAST analysis was performed to identify sequences of Protein Data Bank 
(PDB) proteins most homologous to each of the human myosin sequences. The crystal 
structure of the highly homologous sequence was used as a template for homology 
modeling of a specific human myosin. The PDB IDs of the templates are listed in Table 
2.1. These models, though not atomistically accurate for the whole protein, gave 
approximate geometric predictions for the residues in the motor core, disclosing spatial 





Table 2.1 Modeling templates for human myosin sequences 
Human Myosin 
Sequence 
Modeling Template (PDB 
ID) 
Identity 
MYO1A 1LKX 46% 
MYO1B 1LKX 47% 
MYO1C 1LKX 49% 
MYO1D 1LKX 48% 
MYO1E 1LKX 49% 
MYO1F 1LKX 48% 
MYO1G 1LKX 46% 
MYO1H 1LKX 45% 
MYH1 2W4A 93% 
MYH2 2W4A 92% 
MYH3 2W4A 87% 
MYH4 2W4A 93% 
MYH6 4DB1 92% 
MYH7 4DB1 99% 
MYH8 2W4G 91% 
MYH9 1BR1 85% 
MYH10 1BR1 84% 
MYH11 1BR1 94% 
MYH13 2W4G 90% 
MYH14 4DB1 73% 
MYH15 4DB1 70% 
MYH16 2YCU 100% 
MYO3A 1W9J 36% 
MYO3B 1LKX 37% 
MYO5A 1OE9 94% 
MYO5B 1OE9 75% 
MYO5C 1OE9 68% 
MYO6 2V26 98% 
MYO7A 1W9J 43% 
MYO7B 1W9J 41% 
MYO9A 1W9J 39% 
MYO9B 1W9J 41% 
MYO10 1W9J 43% 
MYO15 1W9J 43% 





MYO18A 1BR1 31% 
MYO18B 1BR1 25% 
 
2.3 Identify key structural elements governing unique functional characteristics of 
different myosin families 
2.3.1 A phylogenetic hierarchy defines the divergent levels for comparative 
sequence analysis 
To identify residues that are conserved among a myosin family or subfamily and 
unique when compared with residues of other myosin families or subfamilies, we first 
formed groups of myosin sequences based on the results of their phylogenetic analysis. 
The phylogenetic tree of the 1984 aligned sequences of myosin motor domains by 
Odronitz and Kollmar [22] was used, focusing on groups of sequences phylogenetically 
close to 37 human myosin sequences. Four comparison levels of phylogenetic hierarchy 
were assigned (Fig. 2.1). The highest comparison level is at the first branches from the 
unrooted center with >90% bootstrapping [19-21], grouping into the 13 conventional 
myosin families I, II, III, V, VI, VII, XI, X, XV, XVI, XVIII, XIX, and XXXV. At this 
level, all sequences of the 1984 sequences belonging to one of these 13 myosin families 
are grouped as a primary group, while all the rest sequences are grouped as the compared 
group. Using myosin I as an example, this comparison level allows us to identify which 





same alignment locations. Among these 13 myosin families, myosins I, II, III, V, VII, IX, 
and XVIII possess subfamily members of human myosins, thus requiring additional 
comparison levels. An additional comparison level was introduced to myosins III, V, VII, 
IX, and XVIII to compare their two or three subfamilies. Members in a phylogenetic 
branch containing a human myosin of one of the subfamilies were grouped together (see 
Supplemental Information for the sequences in each group). One group was compared 
against the rest of the groups in a family to identify conserved and unique residues. For 
myosin I, two additional comparison levels were introduced; for myosin II, three 
additional comparison levels were introduced (Fig. 2.1). For example MYH6 (α-cardiac 
myosin) and MYH7 (β-cardiac myosin) were compared at the lowest comparison level in 






Figure 2.1 Human myosin families comparison levels 
2.3.2 Comparing myosin I to all other myosins revealed its unique SH1-relay helix 
interactions 
Myosin I is a large family of single-headed myosin with low duty ratio with slow 
ADP release rate and two discrete displacement phases [74]. Potentially family-specific 
residues determine its unique kinetics and mechanics. Comparing 337 myosin I 
sequences to 1647 sequences of other myosins, we identified myosin I-specific residues 
based on the combined scores and listed the top 30 myosin I-specific residues in Table 
2.2. These residues were classified according to structural motifs and numbered based on 
the residue number of human myosin 1C. Potentially these residues are functionally or 
structurally important for specific tasks of myosin I. Intriguingly, 17 of 30 top myosin 
I-specific residues are located in the relay, SH1, SH2, and the converter. Specifically, 5 of 
14 SH1 residues are in this short list, suggesting myosin I possesses a highly unique SH1 
helix when compared with other myosins. Mapping these myosin I-specific residues to 
the model structure of human myosin 1C, we found the myosin I-specific relay helix 
residues I415, L419 and F439 are in close proximity to the MYO1-specific SH1 residues 
L614, L616， N619 and V622. These extensive hydrophobic interactions unique for 
myosin I result in the tight coupling between the C-terminal of the relay helix and the 
SH1 helix (Fig. 2.2), likely introducing a unique transduction mechanism from the ATP 





crystal structure of Dictyostelium Myo1E [75] where the location of SH1 in myosin I 
substantially differs from the SH1 location of myosin II when aligning the crystal 
structural of DdMyo1E with DdMyoII. We were not able to identify many conserved and 
unique residues in the actin binding regions, probably because their kinetics is subfamily 
dependent. And we identified some specific residues in upper and lower 50 kDa domains 
and these may be related to the unique kinetics such as the slow ADP release rate of 
myosin I. 
 
Table 2.2 Top 30 myosin I-specific residues with top conservation/uniqueness scores 
where the residue IDs of HsMYO1C were used and residues were clustered by their 
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Figure 2.2 Conserved and unique residues form hydrophobic coupling between the relay 
helix and the SH1 domain in myosin I family. 
 
2.3.3 Identification of clusters of unique residues in myosin I subfamilies 
The second level of comparison includes four groups: myosin Ia/myosin 1b, myosin 
Ic/myosin Ih, myosin Id/myosin Ig, and myosin Ie/myosin If. Myosin Ia contributes to 
membrane-cytoskeleton adhesion and acts as an important player in membrane 
movement and structural stability [76]. Myosin Ib is found at the plasma membrane and 
in cell protrusions such as membrane ruffles [77-78]. The actin-activated ATPase activity 





Comparing the group of sequences of myosin Ia/myosin Ib against the sequences of the 
other three groups (myosin Ic/myosin Ih, myosin Id/myosin Ig, and myosin Ie/myosin If), 
we found a cluster of myosin Ia/myosin Ib-specific residues in loop 2 of the actin binding 
region, suggesting their potential roles in actin binding kinetics of myosin Ia/myosin Ib. 
The ATP-induced dissociation of actin from actin-myosin Ib is much slower than other 
myosin I sub families. We detected 12 distinct loop 4 residues between myosin Ia and 
myosin Ib, potentially distinguishing their actin dissociation rate.  
 
Myosin Ic links the actin cytoskeleton to cellular membranes, facilitates G-actin 
transportation, and plays roles in signal transduction and membrane trafficking [83]. 
Myosin Ih is one of the least known myosins with limited knowledge of its functions [84]. 
When comparing myosin Ic/myosin Ih to other groups in this level, we found a cluster of 
100% conserved and unique myosin Ic/myosin Ih residues within the converter. Another 
cluster of myosin Ic/myosin Ih-specific residues lies at the N-terminal region. These 
conserved and unique residues in the converter and the N-terminal may be linked the 
unique functions of myosin Ic/myosin Ih, as the motor domain in myosin Ic is known to 
play roles in delivering G-actin transport in lamellipodia to the leading edge [85]. The 
next level of comparison between myosin Ic and myosin Ih revealed that each of these 
two subfamilies possess a group of subfamily-specific N-terminal residues distinct from 







Myosin Id is known to control left–right asymmetry [86], and it has an unexpectedly 
large step size when compared with other myosins. This large step size was achieved by a 
large rotation of the lever arm [87]. Myosin Ig regulates cell elasticity by deforming actin 
network at the cell cortex[88]. We found a cluster of conserved and unique residues in the 
N-terminal, the converter, and loop 2 in the actin binding site. These residues may be 
responsible for the rotation of the lever arm and its associated kinetic control. Although 
myosin Id and myosin Ig are phylogenetically grouped together, surprisingly we found an 
extended list of residues distinguishing these two subfamilies, including clusters of 
residues in the N-terminal and loop 4 regions, potentially responsible for their distinct 
roles in cells. 
 
Myosin Ie and myosin If are known to have different structures from other myosin I 
families with a long tail segment containing an SH3 domain [20]. Myosin Ie plays a role 
in podocyte and kidney function[89]. Both myosin Ie and myosin If are expressed in 
immune cells, although myosin Ie predominantly in B cells while myosin If in 
neutrophils [90]. In the comparison between myosin Ie/myosin If and other myosin I 
families, 83 out 673 residues are 100% conserved and unique for myosin Ie/myosin If, a 





arrangement from other myosin I proteins. The myosin Ie/myosin If-specific residues 
mainly concentrate within N-terminal and converter domain, suggesting their potential 
roles in the energy transduction toward the unique tail region. 
 
Although myosin Ie and myosin If are highly similar in the N-terminal and the 
converter, each of them still possesses a group of subfamily-specific residues in these two 
regions distinguishing them from each other. These myosin Ie-specific or myosin 
If-specific residues may be responsible for their differential expressions in different cell 
populations [90]. Note that their actin binding regions also possess distinct residues 
especially in loop 4 and helix-turn-helix, including clustered residues E302, E303 and 
F304.  
 
2.3.4 Myosin II-specific residues form two clusters, one around SH1 and the other 
close to the cardiomyopathy loop 
Myosin II (MYH) is a large family of contractile proteins including skeletal muscle, 
smooth muscle, cardiac muscle, and non-muscle cytoplasmic subfamilies. Myosin II’s of 
different subfamilies possess different duty ratios and kinetics [91]. Comparing myosin II 
with all other myosins, we identified a group of 30 residues that are conserved among all 
myosin II subfamilies but distinct from all other myosin families. Mostly interesting, 3 of 





in terms of conservation and uniqueness scores. As SH1 was also found special for 
myosin I, we compared the SH1 domain among all myosin families using Weblogo plots 
[92] (Fig. 2.3). In the weblogo plots, the overall height of a stack indicates sequences 
conservation, higher the symbol higher the conservation. And the height of symbols 
within one stack reflects their relative frequencies in this alignment column. The 
comparison of the SH1 domain shows that it is close to enough to determine which 
family a myosin protein belongs to by seeing the SH1 sequence alone. For example, 
N700 and G705 (residue ID based on human MYH1) are highly conserved among 











Figure 2.3 Weblogo plot of unique signature of the SH1 domain in each of the myosin 
families. 
 
Examining the locations of myosin II-specific residues in the model structure of 
human MYH1, we found 9 of 30 myosin II-specific residues are clustered together, with 
residues from SH1, SH2, the N-terminal and the relay helix (Fig. 2.4A). T178 of the 
N-terminal is close to the ATP binding site, and C699 and N700 in the loop between SH1 
and SH2 are close to T178. N700 is close to another N-terminal residue F122, which is 
adjacent to L121 and S119. These residues are clustered closely with M496 in the relay 
helix as well as G705 and C709 in SH1 adjacent to the converter. Thus, one side of this 
cluster of residues is close to the ATP binding site and the other side is next to the 
converter, potentially contributing to the required contractile functions of all myosin II 
proteins.  
 
Besides the cluster close to SH1, we also detected a group of 6 myosin II-specific 
residues close to the cardiomyopathy loop (Fig. 2.4B). P405, R406, K408, G410 and 
Q418 in the cardiomyopathy loop, K408 and Q410 interact with P405 and R406, where 
P405 is close to the other two myosin II-specific residues N605 and Q418, which is next 
to loop 4. All these residues are adjacent to the actin binding site, potentially controlling 






Figure 2.4 (A) Clustering of myosin II specific residues around SH1, N-terminal and relay 
helix. (B) Clustering of myosin II specific residues around cardiomyopathy loop. 
 
2.3.5 A subset of myosin II-specific residues match mutated residues in 
hypertrophic cardiomyopathy patients 
Several of these myosin II-specific residues have been reported in mutations of 
β-cardiac myosin, a myosin II in cardiac muscles (MYH7), causing hypertrophic 
cardiomyopathy (HCM) [93-94]. For example, R252
R249
 (residue ID for human MYH1 in 
the large font and residue ID for human MYH7 in the superscript) in the upper 50 kDa 
domain, R406
R403
 in the cardiomyopathy loop, M496
M493





 in the lower 50 kDa domain, and N700
N696
 in SH1 domain are the conserved 







 in MYH11 has also been identified in patients with thoracic aortic disease [98]. 




 have been shown above to located at 




 belong to the cluster close to the 
actin binding site, reassuring their importance in the mechanical or kinetic roles of 
myosin II. L520
L517
 interacts with the relay helix, while R252
R249
 is adjacent to the HW 
helix, both potentially contributing to mechanical transduction inside the motor domain. 
 
2.3.6 Skeletal muscle myosins and cardiac myosins 
One phylogenetic branch of myosin II consists of the most widely studied 
skeletal/cardiac muscle myosins, including four subgroups: MYH1/2/4/8 (skeletal muscle 
myosins), MYH6/7 (cardiac myosins), MYH3 (embryonic skeletal muscle myosin), and 
MYH13 (extraocular skeletal muscle myosin) [20]. Intriguingly, sequence analysis 
comparing this subgroup of skeletal/cardiac myosins with other myosin II’s shows that a 
cluster of skeletal/cardiac myosin-specific residues locate around the helix-turn-helix and 
the loop 2 region.  
 
Specifically, close to the ATP binding site, R240 (residue numbers based on human 
MYH1) of switch I and E681 in a loop leading toward the SH2 helix are conserved and 
unique among skeletal/cardiac myosins. H695 in SH2 and K711 in the adjacent SH1 





adenosine of ATP, while F196 at the other end of the HF helix is also conserved and 
unique within this subgroup. F196 is close to another cluster of skeletal/cardiac 
myosin-specific residues, including K260, D221, I223, as well as H254, D265, H672 in 
the central β-sheet. H672 is at a distance possible to indirectly interact with F491 of the 
relay helix, which is in close proximity to M518 at the end of the relay loop and N665 on 
the HW helix. There are another three skeletal/cardiac myosin-specific residues on the 
HW helix, N658, R656, and S652. The latter two residues form a cluster with E538 on 
the helix-turn-helix, Q645 on the loop 2, and K601, all close to the actin binding site. All 
together, skeletal/cardiac myosin-specific residues form an allosteric network propagating 
from the ATP binding site to both the actin binding site and the structure leading toward 
the converter. 
 
Comparing cardiac myosin MYH6/7 to skeletal muscle myosins MYH1/2/4/8, we 
found at least three clusters of residues distinguishing them from each other. On loop 1, 
cardiac myosins have conserved and unique A200, I201, and R204 (residue IDs for 
human MYH6), while skeletal muscle myosins have V201, T202, and K205 (residue IDs 
for human MYH1) in the corresponding alignment locations. On the helix-turn-helix, 
cardiac myosins possess M532, T548, A551, and N556, while skeletal muscle myosins 
possess F534, S550, N553, and Q558 in the corresponding positions. Their converter 





I726, P729, G743, L751, and N756, while the mapping residues of skeletal muscle 
myosins are S715, K723, K727, V728, A731, A745, I753, and T758. These three distinct 
clusters of residues may dictate their different ATP binding, actin binding, and power 
generation, respectively. 
 
Comparing MYH3 with other skeletal muscle myosins and cardiac myosins, we 
found clustering of 6 conserved and unique residues in loop 1. Similarly, at the same 
comparison level, we found 5 MYH13 specific residues also cluster in loop 1. The 
specific residue in these regions could be responsible for the specific expression location 
for MYH3 and MYH13.  
 
MYH1, MYH2, MYH4, and MYH8 are highly homologous in sequences, so only 
limited numbers of subfamily-specific residues were found when comparing them from 
each other. Notably S346 and R349 on the HL helix are MYH1-specific; E421 and S424 
on the HO helix are MYH2-specific; V583 in the lower 50k-Da domain, V339 on the HK 
helix, and A346 on the HL helix are MYH4-specific; T626, Y627, A636 and S645 in loop 






2.3.7 Comparison between MYH6 and MYH7 
α-cardiac myosin (MYH6) is primarily expressed in atria and β-cardiac myosin 
(MYH7) is primarily expressed in ventricles. α-cardiac myosin has fast contraction 
velocities but produces small forces, while β-cardiac myosin has slow contraction 
velocities but produces large forces [99]. 92% of residues of human α- and β-cardiac 
myosins are identical, but the minor differences play essential roles in controlling their 
kinetic and mechanical differences. We found a group of residues close to the ATP 
binding site and another group of residues close to the actin binding site distinguishing 
these two cardiac myosin isoforms. A segment of loop 1 close to the ATP binding site is 
drastically different between two myosins, where residues 209-213 for α-cardiac myosin 
are NxNAN, while residues 209-212 for β-cardiac myosin are QxPG, even with a 






Figure 2.5 Weblogo plot of a segment of aligned loop 1 region of α-cardiac myosin and 
β-cardiac myosin. For this segment, α-cardiac myosin (MYH6) has a pattern NXNAN, 
while β-cardiac myosin (MYH7) has a pattern QXPG. 
 
Around the ATP binding site, a residue prior to loop 1 (V197 for β-cardiac myosin vs. 
S197 for α-cardiac myosin), residues close to switch I (D282, I313, T318 and T319 for 
β-cardiac myosin vs. N283, V314, V319, and S320 for α-cardiac myosin), and residues in 
the loop leading to SH2 (T678 and S680 for β-cardiac myosin vs. R680 and A682 for 
α-cardiac myosin) also distinguish them from each other. Close to the actin binding site, 
α- and β-cardiac myosins have highly distinct loop 2 residues (Fig. 2.6), where S623, 
G632, D633, S634, G635, G640 and K641 are conserved and unique for α-cardiac 
myosin, while A622, N623, G626, P632, K639 and A640 are conserved and unique for 






Figure 2.6 Weblogo plot of highly distinct loop 2 region between α-cardiac myosin and 
β-cardiac myosin. 
 
Other residues associated with the actin binding site that distinguish these two 
isoforms include a residue in the cardiomyopathy loop (S417 for α-cardiac myosin vs. 
N416 for β-cardiac myosin.), three residues prior to loop 2 (M618, A619 and S623 for 
α-cardiac myosin vs. L617, S618 and A622 for β-cardiac myosin.), one residue in the HT 
helix (E596 for α-cardiac myosin vs. Q595 for β-cardiac myosin.), and two residues at the 
root of loop 4 (Y360 and D381 for α-cardiac myosin vs. F359 and E380 for β-cardiac 
myosin.). All the residues distinguishing these two cardiac myosins may be responsible 
for their distinct mechanical and kinetic properties. 
 
2.3.8 Non-muscle myosins and smooth muscle myosins 
Non-muscle myosins and smooth muscle myosins group contains MYH9/10/11/16. 
MYH9 is nonmuscle myosin IIA, while MYH10 is nonmuscle myosin IIB. MYH11 is 
smooth muscle myosin II, a major element for hollow visceral organs [100]. MYH16 
expresses in the masticatory muscles of mammals [101]. The sequences of this group of 
myosins are similar to each but evolutionary different from skeletal/cardiac myosins.  
 





muscle myosins and cardiac myosins group, we found two clusters of conserved and 
unique residues. One cluster locate around the actin binding sites, the other one lies in the 
N-terminal domain and upper 50kDa domain potentially connecting the ATP molecule 
and the converter domain. Fig. 2.7 shows the cluster of conserved and unique residues 
within the actin binding site. W559 (residue IDs for human MYH16) in the 
helix-turn-helix interacts with M666 in loop 2 as well as Q672 which is adjacent to loop 2. 
F411, L416, T420 and A430 cluster around the cardiomyopathy loop  
 
Figure 2.7 Clustering of conserved and unique residues around helix-turn-helix (W559), 
loop 2 (M666, Q672) and cardiomypathy loop (F411, L416, T420, A430). 
 
The rest of specific residues concentrate around the N-terminal and the upper 50kDa 





Notably, L215 links the residues around the ATP molecule to other conserved and unique 
residues in the N-terminal and the upper 50kDa domain. This cluster potentially forms 
the energy-conversion allosteric network from ATP binding sites to the converter. 
 
In the comparison between MYH16 and MYH9/10/11, we found a conserved and 
unique residue Q486 locates in the switch II loop leading to the relay helix. At the same 
alignment column MYH9/10/11 and as well as other MYH sequences are highly 
conserved in either D or E. Switch II connect the ATP binding pocket to the relay helix 
and a specific residue close to the relay helix could be crucial for MYH16’s unique 
function. We also identified clusters of residues in the N-terminal and loop 2 distinct 
MYH16 and MYH9/10/11. The conserved and unique residues in the N-terminal, loop 2 
and switch II loop could possibly be the reason for MYH16 superfast contraction speed. 
 
In the next level of comparison we compared non-muscle myosins MYH9/MYH10 
and smooth muscle myosin MYH11 respectively. Comparing smooth muscle myosin with 
non-muscle myosin, we found a cluster of smooth muscle specific residue locate within 
and around loop 2, such as M631, K633, S637, S638 and S643, as well as D617 in the 
HV helix prior to loop 2. We also found a smooth muscle specific residue V468 in the 
switch II loop leading to the relay helix. Some other smooth muscle specific residues 





domain, A692 and E697 in the SH2 helix. Smooth muscle specific residue around ATP 
binding sites may suggest a different ATPase mechanism from non-muscle myosins. 
 
Recent studies of these two myosin proteins have shown that MYH9 is several folds 
faster than MYH10, both in its rate of ATP hydrolysis and in its rate of movement of actin 
filaments [102]. Comparison between MYH9 and MYH10 shows a cluster of conserved 
and unique residues within loop 2. For example, at the alignment column of F636 and 
R639, MYH9 sequences are highly conserved in F and R respectively, while MYH10 
sequences are highly conserved in Y/S and K. These distinct residues could be the reason 
for the faster traveling speed and ATP hydrolysis rate in MYH9. 
 
2.3.9 Other myosin II subfamilies 
MYH14 is a non-muscle myosin associated with hearing defects [103]. Comparing 
MYH14 with other myosin-II sequences, we found five specific residues within loop 3. 
Loop 3 is the secondary actin binding site, which binds to actin in the rigor and in the 
weak binding states. The cluster of specific residues within loop 3 suggests a different 
actin binding mechanism in the weak binding states for MYH14. 
 
MYH15 is a least known myosin II. Surprisingly two residues in switch II and the 





highly conserved segment among all myosins, with a signature sequence of DIXGFE at 
its core. MYH15-specific T475 resides at the less conserved position in this segment (X 
of DIXGFE), where X can be A, F, P, or Y for all other myosins. L480 is another 
MYH15-specific residue close to the tip of the relay helix. Because of the important roles 
of switch II in ATPase [104], our finding suggests MYH15 may have unique ATPase 
activities. 
 
2.3.10 Myosin V specific residues cluster around ATP and actin binding sites 
Myosin V is a processive molecular motor that transports intracellular cargo along 
actin tracks with each head taking multiple 72-nm hand-over-hand steps [105-106]. 
Myosin V has a high duty ratio: a single-headed myosin V binds to actin tightly in the 
ADP-bound state [107]. We found a cluster of myosin V-specific residues close to the 
ATP binding site: T212 (residue IDs for human MYO5) in switch I, A683 and C684 at the 
proximal end of the SH1 helix, V161 prior to the P-loop, as well as V171, S172, A173, 
Y175 and R178 in the HF helix between the P-loop and loop 1. T212 is in close 
proximity to another switch I residue S217, a residue highly conserved among all 
myosins and associated with duty ratio control as shown in S217A mutant [108]. In 
addition to A683 and C684, another two residues in the distal end of the SH1 helix, T689 
and S693, are also myosin V-specific, leading toward another cluster of conserved and 





interact with V469 of the relay helix and I105 of the N-terminal. S693 is also in close 
proximity to T75 and S78 of the N-terminal, where S78 further interacts with W701 and 
A756 in the converter. These two clusters of residues span from the ATP binding site to 
the converter, presumably providing unique coupling from the ATP binding to the lever 
arm of myosin V.  
 
Another group of myosin V-specific residues were detected close to the actin binding 
site: W374 prior to the loop 4, W523 in the helix-turn-helix, K632 in the loop 2, R542 in 
the loop 3, as well as T517 and V572 in the lower 50kDa domain. The unique residues in 
the actin binding site may be responsible for myosin VI’s high affinity for actin. A pair of 
lysine residues located in the C-terminal end of loop 2, K632 and K633, have been 
reported to be one of the key reasons for MYO5’s high actin affinity [109], where K632 
is one of the myosin V-specific residues we found. We did not identify K633 because of 
its low conservation among myosin V sequences.  
 
Comparison among myosins Va, Vb, and Vc shows a large group of isoform-specific 
residues close to the actin binding site, especially in loop 2, loop 4, and the 
cardiomyopathy loop. Comparing myosin Va with myosin Vb and myosin Vc, we found 6 
residues in loop 4, 3 in helix-turn-helix, 2 in the cardiomyopathy loop, and 4 in loop 2 are 





myosin Vb vs. V341 for myosin Vc), a residue in the helix-turn-helix (M515 for myosin 
Va vs. V516 for myosin Vb vs. L513 for myosin Vc) and a residue in HV helix leading to 
loop 2 (L588 for myosin Va vs. V588 for myosin Vb vs. L586 for myosin Vc). These 
differences may be responsible for their distinct duty ratios and actin binding affinities.  
 
2.3.11 Myosin VI has a unique converter domain 
Myosin VI is a motor moving toward the minus (-) end of actin filaments, opposite to 
the directionality of all other characterized myosins [110]. Mutations in myosin VI lead to 
hearing impairment and vestibular dysfunction in both humans and mice. For example, 
E216V, H246R and C442Y within the myosin VI motor domain are associated with 
sensorineural deafness [111]. The mutation of D179Y close to loop 1 destroys gating 
through disruption of the transducer region and ultimately leads to deafness [112].  
 
We have previously conducted a similar sequence analysis and have reported a series 
of myosin VI-specific residues [113]. Mostly notably, myosin VI shows a unique 
converter with 7 residues locating in this region: Y715, L729, F734, K762, F763, F766 
and M770. These myosin VI-specific residues are potentially responsible for the unique 
conformational difference of the converter observed in the crystal structures. Some of 
these converter residues, K762, F763, F766 and M770, cluster with other residues from 





Our simulation studies revealed interactions of these residues at the interface between the 
converter domain and the motor domain are responsible for positioning the converter in 
the pre-stroke conformation [113].  
 
Figure 2.8 Myosin VI specific residues cluster around the converter domain, A91 and 
K133 are in the N-terminal domain; V697 and M701 belong to the SH1 helix; and K762, 
F763, F766, and M770 belong to a helix of the converter domain. 
 
2.3.12 Myosin VII specific residues map to the mutations in patients with USH1B 
Myosin VII plays important roles in cell adhesion [114] and is thought to be a 
processive motor [115]. It possesses five IQ motifs beyond its motor domain and 
two FERM domains in the tail region [116]. In human, myosin VIIa mutations are 





sensorineural hearing loss and retinitis pigmentosa that gives rise to gradual blindness 
[117]. Both myosin VIIa and VIIb have high duty ratios and different from other myosins, 
myosin VIIa has a much faster ATP hydrolysis rate when binds to actin [118].  
 
Four of the myosin VII-specific residues we found are known to be associated with 
USH1B [119], including G74 (residue IDs for human MYO7A) and D75 in the 
N-terminal, L170 of the HF helix right beyond P-loop, as well as Q234 interacting with 
switch I and switch II. Mutations of any of these residues caused deafness [120], 
confirming their functional importance on myosin VII. In addition to these 
disease-related residues, we also found that myosin VII-specific residues cluster around 
the N-terminal, the SH1 helix and the converter. Notably, residues I71 and S100 of the 
N-terminal are in close proximity to residues I674, D730 and D733 of the converter, 
while residue T98 in the N-terminal is close to the residue M661 and M662 in the SH1 
helix. Close to the ATP binding site, H182, S183, and W184 in loop 1 as well as N443 in 
switch II are myosin VII-specific. These residues may be responsible for the unique 
control of ATP hydrolysis cycle of myosin VII. 
 
Comparison between myosins VIIa and VIIb shows two large groups of 
isoform-specific residues, one close to the actin binding site including residues in loop 2, 






2.3.13 Myosin IX has an extended loop 2 for calmodulin binding 
Myosin IX plays roles in Rho signaling pathways [121]. MYO9A has been 
implicated in the regulation of epithelial cell morphology and differentiation, whereas 
MYO9B has been shown to play an important role in the regulation of macrophage shape 
and motility [122]. It is known that myosin IX has a large N-terminal extension and a 
calmodulin-binding insertion in loop 2 [123]. Our analysis indeed found 7 myosin 
IX-specific residues in the N-terminal segment of loop 2, absent in all other myosins. The 
most conserved and unique residue, W702 (residue ID of human myosin IXa), is the first 
residue of the 1-8-14 calmodulin binding motif [124]. We have also identified 4 myosin 
IX-specific residues in the N-terminal. Comparison between myosins IXa and IXb 
revealed multiple drastically different segments with 155 distinct residues, especially in 
the regions of loop 2 (residues 720-792), loop 4 (residues 438-448), and an additional 
loop between helices HJ and HK at the actin binding site (residues 368-390). 
 
2.3.14 Myosin XVIII has a novel switch II interacts with ATP differently 
Myosin XVIII is abundantly expressed in stromal cells, showing high supportive 
activity for hematopoietic cell development, though it is also expressed rather 





has an ATP-insensitive actin-binding site. Besides the unique N-terminal domain, a 
flexible loop is inserted at the highly conserved switch II region in the ATPase site in 
myosin XVIII sequences and the most conserved glutamic acid in the switch II region is 
changed to glutamine in all members of myosin XVIII [125]. 
 
We found 4 myosin XVIII-specific residues in switch II: P791, Q794, P796 and 




 replaces the ~100% conserved DIxGFE of switch 
II. It remains to be examined why myosin XVIII possesses this drastic change in switch II, 
especially with a proline residue in this motif. Besides switch II, 8 myosin XVIII specific 
residues lie in the actin binding site, including G676, R686 and F689 in loop 4, D859, 
W881 and R900 in the helix-turn-helix as well as R1001 and F1009 in loop 2. 
 
Comparison between myosins XVIIIa and XVIIIb revealed their distinct N-terminal, 
loop 2, converter, one long segment in the upper 50 kDa domain, and the other long 
segment in the lower 50 kDa domain. Surprisingly, we detected a distinct residue within 
P-loop: S499 in human myosin XVIIIa vs R661 in human myosin XVIIIb. Most of the 






Figure 2.9 Frequency analysis of the alignment column of P-loop residue S499 in human 
myosin XVIIIa. Myosin XVIIIa mutates the highly conserved P-loop residue E to S and 
myosin XVIIIb mutates it to R. 
 
This E of P-loop forms a hydrogen bond with a conserved Q of SH2 in other myosins, 
potentially playing roles in energy transduction toward the converter. The replaced S499 
in myosin XVIIIa and R661 in myosin XVIIIb may lose their interactions with SH2, but 
instead interact with a residue in the bent switch II, potentially the myosin XVIII-specific 
Q of DxPGxQ. The reason of this rerouted interaction from SH2 potentially to switch II 
remains to be explored. 
 
2.3.15 Other myosin families 





have shown human myosin IIIA has an exceptionally high affinity for actin, spending a 
majority of its ATP hydrolysis cycling time on actin [127]. Myosin III is divergent from 
other myosins with an N-terminal protein kinase. This N-terminal segment is beyond the 
motor region of our sequence analysis, so we did not identify myosin III-specific residues 
in this domain.  
 
A group of 7 myosin III-specific residues are located around the actin binding site: 
T661, R664 and N666 (reside ID for human MYO3A) in the cardiomyopathy loop, L780 
and F808 in the helix-turn-helix, P874 and N880 in loop 2. These myosin III-specific 
residues in the actin binding sites could be responsible for its high affinity for actin. 
Another group of 6 myosin III-specific residues are at the segment of the converter right 
beyond the SH1 helix: including S989, H990, Y1042, Y1043, H1044 and E1046. These 
residues are adjacent to the N-terminal, possibly playing roles in coupling the kinase 
functions of the N-terminal and the motor function. Myosins IIIA and IIIB differ 
significantly in their N-terminal, loop 2, loop 4, and the relay helix. 
 
Myosin X is localized at the tip of filopodia and induces the formation of filopodia 
[128]. A number of myosin X-specific residues are close to the actin binding site, 
including T343, A344 and G346 in loop 4, L380 and E384 in the cardiomyopathy loop, 





residues in the other side of the actin binding site (helix-turn-helix, loop 2, and loop 3) is 
myosin X-specific. 
 
Myosin XV is critical for the formation of stereocilia in hair cells in cochlea [129]. 
Several mutations in myosin XV have been reported to be associated with human 
nonsyndromic deafness [130-131]. A majority of myosin XV-specific residues are 
localized close to the actin binding site, including Y1489, E1499, and S1505 in loop 4, 
E1508 and I1509 right after loop 4, T1532 and T1541 in the cardiomyopathy loop, 
G1522 and D1550 close to the cardiomyopathy loop, D1663, C1679, H1680 and Y1681 
in the helix-turn-helix, as well as L1688, Y1689, E1698 and R1724 close to the 
helix-turn-helix.  
 
Myosin XVI is the least studied myosin family important for brain development 
[132]. One cluster of myosin XVI-specific residues are located in the N-terminal; the 
other cluster of myosin XVI-specific residues lies in the actin binding sites, including 
K971, K1020 and K1021 in the extended loop 2, G911, N912, G913 and N914 in loop 3, 






3. Structural-function relationship in Myosin VI 
3.1  Significance of myosin VI 
Myosin VI plays important roles in transporting, anchoring, and secreting in diverse 
cellular processes and is related to various human diseases. It maintains the stereocilia in 
the inner ear hair cells where mutations in myosin VI lead to human hereditary deafness 
[133]. Myosin VI also transports coated and uncoated vesicles in clathrin-mediated 
endocytosis [134], facilitates E-cadherin-mediated border cell migration [135], promotes 
cell adhesion during epithelial morphogenesis [136], and is involved in secretory vesicle 
fusion at the plasma membrane [137]. Recent studies have shown its roles in maintaining 
malignant properties of human prostate cancer [138] and promoting the dissemination of 
human ovarian cancer [139]. 
 
The unique structural arrangement and mechanochemical characteristics of myosin VI 
may contribute to its distinct cellular functions described above [137]. Myosin VI is the 
only known myosin moving toward the (-)-end of actin filaments [140], possesses new 
conformational changes never observed in any other myosin [141], has a high duty ratio 
spending most of the time of its ATPase cycle in the actin-bound state [142-143], moves 
in a large step size despite its short light chain domain [144], and moves processively in 
the absence of detailed tuning of structure and intramolecular communication [145]. The 





variations contributing to the observed variable step sizes [148].  
 
Structures of myosin VI revealed several unique structural elements. A unique insert 
beyond the converter domain (Pro 774 to Tyr 812) positions the lever arm toward the 
opposite end of other myosin structures [149]. This unique insert is composed of two 
parts: the proximal insert beyond the converter domain and the distal insert prior to the 
IQ motif. The proximal insert is a helix containing a 120° bend, closely interacting with 
the converter domain. The distal insert binds calmodulin (CaM) to form a part of the 
lever arm. Removal of this unique insert converted myosin VI to a (+)-end directed motor 
on actin filaments [146, 150]. We have recently identified that removing the α-helix of 
residues Asp 773 to Cys790 in the proximal insert converts myosin VI to a (+)-end motor 
[72]. Among these 18 amino acids, P774 is widely regarded as a proline kink to play an 
essential role in bending anα-helix toward the (-)-end [149]. Although the preferred angle 
of P774 has the ability to bend an α-helix, it remains unclear why the structure of residues 
773-790 can wrap around the converter domain to direct the lever arm toward the (-)-end 
direction.  
 
Several novel conformational changes have been shown in the prestroke crystal 
structure [141]. The structure shows a large rotation angle of the converter domain 





converter domain. An extra 10° converter domain rotation of myosin VI between the 
converter domain and the motor domain was observed compared to myosin II [141]. One 
big surprise of myosin VI’s structures responsible for the reverse directionality is the 
rearrangement of the converter domain. Unlike myosin II whose converter domain rotates 
as a rigid body, myosin VI’s converter domain changes the relative position of several of 
its helices when rotating from the poststroke state to the prestroke state. Crystal structures 
showed that the three helices of residues 712-722, 732-741, and 763-770 in the converter 
domain have dramatically different orientations from any other myosin structures, leading 
to a repositioning of the proximal insert.  
 
3.2  Important converter and motor domain interactions in Myosin VI 
Conservation analysis and frequency analysis of amino acid appearance gave us a list 
of myosin VI-specific residues, including three unique residues of myosin VI: P444 on 









Table 3.1 Top 15 conserved and unique myosin VI residues comparing to all other myosin 
families. 
residue conservation uniqueness gap structure motif 
E575 100.0% 100.0% 1821 between S1E & S2E Loop 3 
P444 100.0% 99.7% 13 between HO & S5B Upper 50kDa 
C587 100.0% 98.7% 13 S3E Lower 50KDa 
N62 100.0% 98.0% 37 ahead of HC N-terminal 
M675 100.0% 97.1% 20 between S3B & HX SH2 
D573 97.1% 100.0% 1693 between S1E & S2E Loop 3 
A91 100.0% 96.9% 57 between S1B & S2B N-terminal 
M701 100.0% 96.7% 19 HY SH1 
F763 100.0% 99.1% 31 beyond S3F Converter 
H568 97.1% 99.1% 1314 between S1E & S2E Loop 3 
S696 97.1% 99.1% 19 HY SH1 
F445 100.0% 95.2% 13 between HO & S5B Upper 50kDa 
F766 100.0% 97.4% 31 beyond S3F Converter 
G682 100.0% 94.5% 18 HX SH2 
Y715 100.0% 94.3% 21 HZ Converter 
 
To examine the roles of these myosin VI-specific residues, we conducted a total of 
1-μs MD simulations for wild- type myosin VI and mutant models F763L, M701C, and 
P444D (3 different seeds x 4 constructs x 50-ns) and four control simulations L700A, 





residues were replaced by their corresponding residues in myosin II (scallop myosin). For 
example, comparing the crystal structure of myosin VI (2BKI) and scallop myosin II 
(1QVI), we found the corresponding residue in myosin II is L767, and thus created a 
mutant model of myosin VI F763L. The comparison of conformational equilibria 
between the wild-type structure and a mutant model illustrated how a corresponding 
mutation may affect the mechanics of the molecule. 
 
MD simulations of the wild-type and mutant structures were conducted using 
Groamcs [151]. Each protein was neutralized and solvated in TIP3P water box with 
periodic boundary conditions. AMBER99 force field [152] was used. The system was 
first energy minimized using the steepest descent algorithm. After energy minimization, 
simulation was carried out for 10 ps with protein constrained to equilibrate the water 
molecules. MD simulation without protein constraints was then performed for 20 ns. The 
LINCS algorithm was applied to constrain all bond lengths and angles. A 2 fs time step 
was used for all runs. Berendsen temperature (300K) and pressure coupling (1.0 bar) 
were used, with time constants of 0.1 and 0.5 ps, respectively. Particle-mesh Ewald 
summation was used for electrostatic interactions with a 9 Å cutoff distance. The van der 
Waals neighbor list cutoff distance was 14 Å. The equations of motion were integrated 






The location of F763 is close to the interface of the converter domain and the motor 
domain. For the wild-type structure, our MD simulation showed that F763 interacts with 
the backbone of K133 in the motor domain through a 50-ns trajectory. We then examined 
the conformational equilibria of the mutant models. We found that the mutation from 
F763 to L763 causes the loss of interactions between L763 and K133. Loss of such 
interactions causes the detachment of the converter domain and the motor domain (Fig. 
3.1A). Trajectories of the backbone distances between K133 and residue 763 show the 
difference between a wild-type and F763L mutant (Fig. 3.1B), with a shifted mean 
distance and an altered standard deviation (Fig. 3.1C). The differences of 763-K133 
distance between the wild-type and the mutant structures were statistically significant for 
the simulation results of all three seeds (p value <1E-5). This result indicates F763 in 
myosin VI plays a potentially important role in holding the converter domain at its 







Figure 3.1 MD simulation showing the change of conformational equilibria perturbing 
the interactions between the motor domain and the converter domain due to a single 
mutation F763L. (A) Snapshots of the interaction between residue 763 and K133 for the 
wild-type (blue) and the F763L mutant (red). The interaction between F763 and K133 was 
lost when mutating to L763, causing the movement of the converter domain away from the 
motor domain. (B) MD trajectories of distances between the backbone atoms of residue 
763 and K133. The trajectory of F763L is more distant than that of the wild-type structure, 
demonstrating the deviation of the converter domain. (C) Histograms of (B) showing a 






In order to validate that the mutation of F763 to L763 was the major cause of the 
missing interactions, we conducted two single-mutation control simulations, where two 
adjacent residues K762 and A764 were mutated to A762 and V764, respectively. We 
performed 50-ns MD runs for each of them, and we measured the pair-wise distance 
between the backbone atoms of F763 and K133 in these two mutant structures. Both 
K762A and A764V showed minimal effects on the distance between F763 and K133 (Fig. 
3.2), supporting the suggested roles of F763L on the interactions between the motor 






Figure 3.2 Comparisons of MD trajectories of structures between the target mutation 
F763L and the control mutations K762A and A764V. The distances between the backbone 
atoms of residue 763 and K133 demonstrate that the mutation of F763L has its 
conformation deviating from the wild-type conformational equilibrium, while the 
mutations of K762A (A) and A764V (B) give negligible perturbation to the conformational 
equilibrium. 
 
M701 is located at the top of the SH1 helix, close to the beginning amino acid of the 
converter domain. We compared the conformational equilibria of the mutant structure 
M701C (red) and the wild-type structure (blue) and found that the converter domain is 
tilted in the mutant structure (Fig. 3.3A). A closer look into the mutation site revealed the 
atomic interaction between residue 701 and 760 of the mutant is different from that of the 
wide-type, affecting the position of the first helix in the converter domain (Fig. 3.3B). In 
the wide-type structure, a hydrogen bond is formed between M701O and P760HG, while 
a hydrophobic interaction is found between M701SD and P760HB2 (Fig. 3.3C). 
 
These two interactions between M701 and P760 likely communicate the 
conformational change from the motor domain to the converter domain. On the contrary, 
there is only one hydrogen bond C701O–P760HG and no hydrophobic interaction in the 
M701C mutant structure. All three seeds of the mutant simulations show the loss of the 





interaction gives less structural support to the converter domain, causing the tilt of the 
converter domain shown in Fig. 3.3C and 3.3D. In order to test that the mutation M701 to 
C701 was the major cause of the tilt of the converter domain, we conducted two more 
control simulations of L700A and Q702A mutants of the adjacent residues. We found that 
both mutations showed similar interactions between M701 and P760 and the same 
orientation of the converter domain, supporting the suggested roles of M701C in the loss 






Figure 3.3 The change of conformational equilibria due to a single mutation M701C 
observed in MD simulation. (A) Tilting of the converter domain (circled) of the mutant 
M701C (red) relative to the wild-type structure (blue). (B) The zoomed-in view showing 
the movement of the helix in the converter domain consisting of residue P760. (C) Atomic 
interactions of the wild-type structure between residue M701 and P760. A hydrogen bond 
and a hydrophobic interaction are labeled with black dash lines. (D) Loss of a hydrophobic 
interaction due the the M701C mutation causing the movement of the helix in the converter 
domain toward the right side in the presented view angle. 
 
We have also conducted MD simulation for the mutant P444D. P444 is located at the 
protein surface distant from major functional sites of the myosin VI’s structure. This 
residue may serve an important role as shown by its conservation and uniqueness, but we 
have not seen significant conformational change within the time range of our simulation. 
 
3.3  Identification of small molecules blocking the myosin VI’s converter rotation 
3.3.1 Virtual screening in drug development and design 
Recent advances in combinatorial chemistry and high throughput screening have made 
it possible for chemists to test a large number of compounds. However, this is still a small 
percentage of the total number that could be synthesized and tested. Virtual screening is a 





small molecules in order to identify those small molecules which are most likely to bind to 
a drug target, such as a protein receptor. Virtual screening allows chemists to reduce a huge 
virtual library to a more manageable size. As the accuracy of the method has increased, 
virtual screening has become an integral part of the drug discovery process [154]. 
3.3.2 Myosin VI specific residues form a binding site 
Myosin VI has been implicated in an increasing number of diseases, including human 
prostate cancer, ovarian cancer, Alzheimer’s disease, and hearing loss. In the sequence 
analysis we performed in Chapter 1, we found that myosin VI specific residues concentrate 
at the interface of the converter and the motor domain. Myosin VI specific residues 
including F763, F766 and M770 in the converter domain, A91, N92 and K133 in the 
N-terminal domain, G662 in the lower 50kDa domain, as well as V697 and M701 in SH1 
helix form a unique binding site connecting the motor domain, relay helix, and the 
converter in the pre-power stroke structure of myosin VI (Fig. 3.4). These residues are 
highly conserved in myosin VI family and unique comparing to other myosin families. 
Since this unique binding site is formed by myosin VI specific residues, the small 
molecules binds to this binding site would not bind to other myosins. The small molecules 







Figure 3.4 Myosin VI specific residues from N-terminal, SH1 helix and the converter 
domain form a unique binding site. 
 
3.3.3 Virtual screening of ZINC clean leads database 
In this study we performed the structure-based virtual screening, which involves 
docking of candidate small molecules into a protein target followed by applying a scoring 
function to estimate the likelihood that the molecule will bind to the protein with high 
affinity. The binding target is the unique binding site we identified in myosin VI 
pre-power stroke structure (PDB ID: 2V26) [141]. A binding box covering this binding 
site is specified, which confines the search of ligand binding conformations inside this 







Figure 3.5 Binding box specified in AutoDockTools. It covers the unique binding site in 
myosin VI including SH1 helix, tip of relay helix, a helix in converter domain and a helix 
in motor domain. The size of the binding box is 24 Å x 21 Å x 21 Å. 
 
Ligands at the 90% Tanimoto cutoff level in the ZINC clean lead database were used 
as the small molecule database, containing 254,582 molecules. Clean lead dataset 
contains only the molecules with benign functionality; all molecules with potentially 
problematic functionality such as thiols, aldehydes, and Michael acceptors are not 
included in this dataset. 90% Tanimoto cutoff level means all clean leads ligands are at 
least 90% similar to at least one of the 254,582 representatives. 
 
 Prior to actual docking run, AutoGrid [155] was introduced to pre-calculate affinity 
maps of interaction energies of various atom types in the box we specified (Fig. 3.5). In 
AutoGrid, the binding box we specified was converted to a 3D grid box. All types of 





was calculated by placing this atom at each grid point in the 3D grid box. AutoDock [156] 
was applied for the virtual screening, AutoDock uses these interaction affinity maps to 
generate ensemble of low energy conformations. It uses a scoring function based on 
AMBER force field, and estimates the free energy of binding of a ligand to binding site 
we specified. The interaction energies between ligand atoms to the binding site do not 
have to be calculated at each step of the docking process but only looked up in the 
respective affinity maps. And of the three different search algorithms offered by 
AutoDock, the Lamarckian Genetic algorithm (LGA) based on the optimization 
algorithm [157] was used, and this algorithm has better performance than either 
simulated annealing or genetic algorithm alone [158]. 
 
 The docking of 254,584 ligands by Autodock yielded about 2.3 millions poses. To 
improve the computational efficiency as well as to ensure selectivity and stable binding, 
four levels of filtering have been applied (Fig. 3.6). In the first level of filtering, we 
filtered out ligands binds to the unique binding site in myosin VI with an estimate 
binding free energy smaller than -8 kJ/mol, which yielded 1,669 ligands for further 
evaluation. This threshold ensured the tight binding between ligand and the unique 
binding site in myosin VI. In the second level, the 1,669 ligands were further tested by a 
second screening, which docked these ligands to other parts of myosin VI pre-power 





better than any other locations on myosin VI were selected as potential molecules, 
yielding 110 ligands. In the third level, we calculated the difference between the binding 
free energy of the site of interest and the minimum binding free energy of all other 
locations. The ligands with a binding free energy difference bigger than 0.6 kJ/mol were 
further analyzed in VMD. The second and third level ensured the selectivity of the 
potential molecules. In the fourth level, we examined the binding conformation of the top 
14 molecules in VMD and identified 10 ligands which bind to the converter domain, 
motor domain and relay helix at the same time. This level of screening ensured the good 
binding conformation between the ligand and the protein. The potential candidate 
molecules were listed in Table 3.2 and ranked by the free energy difference. The chemical 






Figure 3.6 Schematic illustration of the high-throughput virtual screening process. The 
docking, minimization and evaluation of binding free energy were carried out on a 
supercomputer cluster of 128 cores within one week. 
 
Table 3.2 Potential candidate molecules binds to the myosin VI unique binding site. The 
first column is their associated ZINC ID, the second column the binding free energy 
docking to the unique binding site, the third column is the binding free energy docking to 
other part of myosin VI, and the last column is the binding free energy difference. 
Candidate molecules were ranked according to the last column. 
ZINC ID 
binding to the unique 
binding site （kJ/mol） 





ZINC71287908 -8.13 -6.81 1.32 
ZINC59505609 -8.15 -6.87 1.28 
ZINC20251372 -8.04 -7.12 0.92 
ZINC77037422 -8.28 -7.38 0.9 
ZINC75284158 -8.3 -7.45 0.85 
ZINC05225031 -8.08 -7.29 0.79 
ZINC01811739 -8.11 -7.34 0.77 
ZINC22015754 -8.8 -8.12 0.68 
ZINC72143800 -8.04 -7.37 0.67 







Figure 3.7 Chemical structures of top 10 ligands binds to myosin VI unique binding site. 
 
3.3.4 200 ns MD simulation showed the stable ligand-protein interactions 
ZINC71287908, 2-(2-oxo-2-((1,3,5-trimethyl-1H-pyrazol-4-yl)amino)ethyl) benzoic 
acid (C15H17N3O3), was best ranked in Table 3.2, binding to the specific binding site 
tightly with the estimated binding free energy -8.13 kJ/mol, binds to other parts of 
myosin VI with a best binding free energy -6.81 kJ/mol. Thus, this ligand binds to the 
myosin VI unique binding site selectively and it fits into myosin VI unique binding site 






ZINC71287908 has a logP value equals to 1.26, 1 H-bond donor, 6 H-bond receptor 
and a molecule weight 286.311 g/mol. All these chemical characteristics meet the 
requirements of Lipinski's rule of five [159], which ensures high druglikeness of this 
ligand and potentially a good candidate for drug design. 
 
Figure 3.8 (A) ZINC71287908 binds to myosin VI unique binding site. Myosin VI is 
shown in newcartoon and ZINC71287908 is shown in bonds. (B) Myosin VI is shown in 
surface and ZINC71287908 is shown in bonds. 
 
Residues from myosin VI unique binding pocket form close interactions with 
ZINC71287908. The ligand closely interacts with residue K133 and L141 in N-terminal, 
M495 in relay helix, as well as R708, F763, F766, D767 and M770 in the converter. 
Among these 8 residues, 5 are myosin VI specific (Fig. 3.9). This binding conformation 





between them. And binding between the ligand and myosin VI specific residues also 
ensures its selectivity for myosin VI. 
 
Figure 3.9 Interactions between ligand and residues from the unique binding site, myosin 
VI specific residues are colored in red. 
 
To provide further evidence of the binding mode of the ligand ZINC71287908, we 
performed an explicit solvent 200-ns MD simulation for protein-ligand system. Charmm 
force field was applied for the protein, and the CGenFF [160] package in Charmm was 
used to create Charmm force field parameters for the ligand and the simulation was 
performed using GROMACS [151]. Fig. 3.10A shows the tight coupling between the 
ligand and residue K133 and L141 from motor domain as well as the residue R708, F763 
and F766 from the converter during the full course of the 200-ns simulation. Fig. 3.10B 





between the ligand and the converter. The binding between ligand ZINC71287908 and 
myosin VI unique binding site is markedly stable. The hydrogen bond between ligand 
and residue R708 (Ligand:O1-R708:HN) remains stable during the simulation (Fig. 






Figure 3.10 Explicit solvent MD validation of binding mode of ZINC71287908. (A). 
Binding between the ligand and residue K133 and L141 from motor domain (blue) as well 
as R708, F763 and F766 in the converter domain (red) after 200ns simulation. Hydrogen 
bond between the ligand and residue R708 is shown in the black dashed line. (B) Minimum 
distance between the ligand and motor domain (blue), minimum distance between the 
ligand and converter domain (red). (C) Hydrogen bond distance between atom O1 in the 
ligand and atom HN in residue R708. 
 
The interactions between the ligand and myosin VI specific residues introduce tight 
coupling between the converter and the motor domain, which locks the converter from 
rotation. Considering this ligand selectivity for myosin VI’s unique binding site, high 
binding affinity and stable binding, it can be regarded as a promising candidate to block 
the converter rotation in myosin VI and it would assist drug development and design 
targeting myosin VI related diseases. 
 
The potential candidate small molecules listed in Table 3.2 will be further tested 
experimentally using in vitro motility assay method by our collaborators. This method 
coats a layer of single headed myosin VI on the bottom of a cell dish. The actin filaments 
will be added into the cell dish and under the fluorescent microscope we are able to see 
the actin filaments will be dragged and moved by myosin VI coated on the glass. Then 





block the myosin VI converter rotation, we will be able to see a much slower movement 
or even a stop of motion of the actin filaments. 
 
4. Key residues in NS3 helicase 
Our previous correlation analysis [43], which perturbs individual residues and 
computes how that change affects the global fluctuation of a subset of spatially distant 
residues based on an elastic network model, showed that the hotspot residues of NS3 
helicase responsible for ATP binding do not only cover the immediate cleft vicinity, but 
span an extensive atomic network, which could even reach the polynucleotide binding site. 
These hotspot residues are postulated to be involved in the interaction network of 
controlling the ATP coordination and active-site rearrangement for catalysis and can 
potentially be affected by the T324A mutation. Due to change in the microenvironment 
surrounding the hinge, a downward projecting atomic cascade can affect the opening and 
closing of the ATP binding cleft between domains 1 and 2. 
 
In a previous study Gu et al. demonstrated, that water molecules – among residues 
located in both domains 1 and 2 of the ATP-binding cleft – were actively involved with 
ATP coordination and active-site rearrangement for catalysis [50]. It was shown that α and 
β-phosphate groups were coordinated by two spatially restricted water molecules along 





Furthermore, the γ-phosphate groups were coordinated by three positively charged side 
chains (K210, R464 and R467) and water-mediated interactions. Finally, the metal ion 
essential for ATP catalysis located in the octahedral opening of the ATP-binding cleft was 
coordinated by two water molecules and some motif I/II residues (S211 and E291). Thus, 
by analyzing the atomic interaction changes, involving the spatially restricted water 
molecules and the hinge residues, one could describe the atomic details of the flexibility 
modulation of the ATP binding cleft. 
 
Molecular dynamics (MD) simulations have been successfully used for analyzing the 
dynamic behavior of biomolecular structures [161-166]. Since the rational design of 
possible inhibitors require a precise understanding of the mechanochemical behavior of 
their target structures, the MD simulation along with the experimental mutagenesis results 
might shed light into key regions which can be targeted for developing antiviral drugs.  
 
For example, a previous MD study (paired with stochastic-dynamics descriptions) of 
DNA translocation of PcrA helicase demonstrated that ATP hydrolysis couples to 
conformational changes of the motor protein [167]. Their results has also revealed that an 
"arginine finger" residue is essential for stabilizing the reaction intermediate for ATP 
hydrolysis; thereby, providing a means of coupling large scale protein conformational 





conserved “arginine finger” residues, such as R461, R462, R464 and R467 in motif VI, are 
mutated; the polynucleotide unwinding and ATPase activities are severely impaired 
[168-170]. Therefore, with the combination of in silico and in vivo mutational study results 
(similarly to the approach described above), we can possibly provide an inside perspective 
of residue interactions in hotspot regions during nucleic acid binding and ATPase activity 
of NS3. 
 
Up to now, no dynamic analysis has been reported evaluating the effects of hinge 
residue T324 involved in ATP active site coordination of NS3, and its tight coupling to 
nucleic acid binding. In the present work we investigate the behavior of the ATP active site 
microenvironment, using molecular dynamics simulations, starting from a set of protein 
structures. Our MD simulation study focusing on the T324 residue mutation reveals that 
this residue plays a critical role in the atomic coordination of flexibility control of domains 
1 and 2 of the ATP binding cleft through a series of cleft residues. The interaction of these 
residues with residue 324 dictates the entropic degrees of freedom of the ATP binding cleft. 
 
4.1  ATP binding cleft of HCV NS3 helicase became less flexible with T324A 
mutation 
Molecular dynamics (MD) simulation was conducted for two wild-type HCV NS3 





structures (T324A) with and without ATP. Structural relaxation was monitored by 
analyzing the time evolution of the root mean square deviation (RMSD) of the frames 
with respect to the initial structure. The flexible side chain atoms were excluded from 
these calculations and only the backbone atoms were selected for evaluation. In all four 
cases the RMSD showed convergence of the simulation within 20 ns (Fig. 4.1A, B, C and 
D). The structures remain faithful to their starting configuration although an average 
RMSD calculated over all backbone atoms reached about 1.5 Å. This means that the 
initial crystal structure was well maintained during the time steps, thus providing proof of 






Figure 4.1 Time evolution of RMSD of the coordinates of the HCV NS3 helicase 
structures with respect to initial structures. RMSD over the 20 ns MD simulations for 
wild-type structures with (A) and without (B) bound ATP; and for T324A mutant structures 
with (C) and without (D) bound ATP. RMSD for all structures converged over simulation 
time, reaching an average deviation of 1.5 Å. 
 
Since the RMSD is commonly used as an indicator of convergence of the 
structure towards an equilibrium state, Fig. 4.1 clearly demonstrates that for all structures 
the RMSD remained stable around an average value of 1.5 Å over a considerable time 
period (10 ns) of the later part of the trajectory. For this reason, 20 ns simulation length is 
believed to be a sufficient time period to sample the large scale domain dynamics caused 
by the T324A hinge residue mutation. 
 
 Based on the hotspot residues we identified earlier [167]
 
and the locations of these 
residues in the ATP binding cleft, we selected pairs from residue sub-groups located in 
domains 1 and 2 (Q460-E291, R464-D290 and R467-T212) to probe relative motion of 
domains 1 and 2 (Fig. 4.2A). Pairwise distance analysis of these residues showed a change 
in flexibility of the ATP binding cleft after T324A mutation. For example, D290 of domain 
1 and R464 of domain 2, which probes the dynamic behavior of the middle portion of the 
ATP binding cleft, showed that HCV NS3 structures without bound ATP have a significant 





structures demonstrated high fluctuation amplitudes, implying that the RecA-like domains 
1 and 2 form a relatively dynamic active site when ATP is absent (Fig. 4.2B). Histogram 
analysis of this residue pair showed that the mean of the minimum distance was reduced by 
10%, while the standard deviation decreased by over 27% on average when comparing the 
wild-type and T324A mutant structures (Fig. 4.2C). Similar results were reported when 
probing the distances between other domain 1 and 2 hotspot residue pairs. Thus, when the 
hinge residue T324 is mutated to alanine and ATP is not present, the mutation made 






Figure 4.2 The effects of T324A mutation of NS3 helicase on ATP-binding cleft width and 
fluctuation. (A) Hotspot residue locations in the interdomain region of the ATP-binding 
cleft for pairwise distance calculations. Hotspot residue pair Q460-E291 monitors the 
distance at the top, R464-D290 in the middle, and R467-T212 at the bottom section of the 
two domains. (B) Trajectories of minimum distances between hotspot residues R464 and 
D290 for the wild-type structure (red) and the T324A mutant structure (blue). (C) 
Histograms of minimum distance trajectories in (B). There is a 10% reduction of the mean, 
and ~27% decrease in the standard deviation for mutant (blue) relative to wild-type (red) 
structures. 
 
 When comparing the wild-type and mutant helicase structures with bound ATP for this 
hotspot residue pair, we observed that the fluctuation amplitude in the range of 15-18 Å 
was moderate compared to the structures without ATP. Both cases demonstrate a stable 
trend over time; the wild-type structure is especially stable around an approximate mean 
value of 16 Å. The distances are smaller than those when ATP is absent, indicating that 
domains 1 and 2 are more compacted when ATP is present.  
 
Since in this and all other (Q460-E291 and R467-T212) pairwise minimum distance 
measurements, the T324A mutation did not show a significant difference in the ATP bound 
(PDB: 3KQL) cases, we decided to focus on and carry out all further analyses for the 






4.2  Additional trapped water molecules were found in the mutant structure 
To understand the interaction network due to water molecules around the hinge 
region, we analyzed the dynamics of water molecules for a 100 ps MD simulation after 
the original 20 ns MD run. The root mean square fluctuation (RMSF) of each water 
molecule was calculated to identify a set of water molecules with the smallest RMSF 
values, i.e., the water molecules spatially restrained to a particular location. Comparing 
trapped water molecules of wild-type and mutant NS3 helicase apo structures for all three 
seeds, two water molecules (W1 and W2) were localized close to the hinge residue of 
A324 in the mutant structure, absent in the wild-type counterpart in all cases (Fig. 4.3). 
Since W1 and W2 were localized close to the hinge for all seeds, this method provides 
high reproducibility for pinpointing trapped water molecules. We identified a group of 
five residues (Fig. 4.3B) in the vicinity of these trapped water molecules (within 3 Å 
distance), which could be possible interaction members in the atomic network of domain 
1 and 2 flexibility modulation. These residues included S483 and G484 located in the 
kinked region behind the hinge; D454 and V456 residing in the top groove of α-helix of 






Figure 4.3 Recruitment of two stable water molecules close to residue 324 due to the 
T324A mutation of NS3 helicase. Comparison of the structure around residue 324 for 
wild-type (A) and T324A mutant (B) illustrates newly trapped water molecules W1 and 
W2 for the mutant structure. These water molecules form possible atomic interaction 
partners, including residues S483 (orange), G484 (green), H293 (cyan), D454 (yellow), 
and V456 (magenta). (C) Interactions with the water molecules potentially decreasing the 
flexibility of the ATP-binding cleft. The newly trapped water molecules W1 and W2 
potentially interact with H293 in domain 1 and D454 in domain 2 to reduce the flexibility 
of the ATP-binding cleft. 
 
Specifically, H293 in domain 1 forms a hydrogen bond with W2, while D454 in the 
α-helix of domain 2 containing the arginine finger forms a hydrogen bond with W1. W1 
and W2 are also hydrogen bonded to each other, forming a H293-W2-W1-D454 
“hand-cuff” (Fig. 4.3C) preventing flexible movement of the ATP binding cleft between 






4.3  Solvent accessible area differences were observed close to the hinge residue 
In addition to identifying trapped water molecules, we have also examined solvent 
accessible surface (SAS) area and determined the locations with large changes in SAS 
upon mutation of the hinge residue. The SAS analysis showed that there is an obvious 
atomic rearrangement (Fig. 4.4) of the microenvironment surrounding hinge residue T324 
after mutation with respect to water accessibility. By averaging over three different seeds, 
we found three groups of residues close to the hinge residue with large SAS changes: (1) 
residues close to the Walker B motif, including D290, E291, C292, and H293 (~26% SAS 
increase); (2) residues in the immediate neighborhood of the hinge residue 324, from 
A321 to S328 (~20% SAS increase); and (3) a kinked region in domain 2 facing the 






Figure 4.4 Regions of SAS increase in the hinge residue vicinity, including the ATP 
coordination region (290–293, pink), the hinge region of the ATP-binding cleft (321–328, 
violet), and the kinked region behind the hinge (482–484, magenta). 
 
 The T324A mutation opens up a new 3-dimensional (3D) pocket formed by a 
tetrahedron with residue vertexes H293, T324, S483 and D454 where drastic SAS increase 
occurs and the two new water molecules (W1 and W2) localize. Our results show that not 
only the 3D structural opening helped to recruit these solvent molecules, but also the 
surrounding residues with drastic SAS increase were responsible for their atomic 
positioning into this water-pocket. We also found that the SAS increase of H293 and S483 
directly influence the establishment of the hydrogen bonds formed between these residues 
with polar side-chains and the trapped water molecules (W1 and W2) supporting our model 
of water molecule interactions bridging two domains. It is highly possible that the SAS 
increase of P326, G327, S328 and P482 indirectly promote water molecule positioning by 
opening up more solvent accessible surface in this newly formed water-pocket. 
 
4.4  Large normalized root mean square fluctuation was identified in the mutant 
structure 
In addition to identifying regions of drastic SAS increase, we have also examined the 





significant changes in RMSF after mutating the hinge residue. In the RMSF analysis, we 
observed that there was an atomic rearrangement (Fig. 4.5) of the microenvironment 
causing a flexibility decrease in regions of the protein surrounding the hinge residue after 
T324A mutation. By averaging over three different seeds, we found five groups of 
residues close to the hinge residue with large RMSF decrease: (1) residues in the 
immediate neighborhood of hinge residue 324, from A323 to S328 (~42% RMSF 
decrease); (2) a kinked region in domain 2 facing the hinge, including P482, S483, and 
G484 (~40% RMSF decrease); (3) a residue cluster, from A455 to Q460, which connects 
the hinge to the α-helix of domain 2 (~30% RMSF decrease); (4) the α-helix of domain 2, 
which forms the left-hand region of the ATP binding cleft, including R464 and R467 (~26% 
decrease); and (5) residues close to the Walker B motif, including D290, E291, C292, and 






Figure 4.5 Regions of reduced RMSF close to the hinge residue, including the immediate 
neighborhood of the hinge (323–328, blue), the kinked region behind the hinge residue 
(482–484, green), the hinge to α-helix connector (454–460, magenta), the α-helix of 
domain 2 (462–467, cyan), and the residues close to the Walker B motif (290–293, yellow). 
 
 Complementary to the earlier SAS analysis, which identified the residues in the 
hinge vicinity with increased SAS after the T324A mutation, the RMSF analysis further 
probed the dynamic nature of the mechanochemical modulation of domain 1 and 2 
flexibility of the ATP binding cleft. According to the elastic network model developed by 





high flexibility, which is also consistent with previous studies suggesting that domain 2 
undergoes rigid-body movements relative to domain 1 and 3 of the NS3 helicase [46]. 
Here we found that when T324 is mutated to A, there is a drastic RMSF decrease in the 
hinge vicinity (38%) indicating that this flexibility is lost. Furthermore, the RMSF of the 
gatekeeper residue H293 dramatically drops by 46% relative to the wild-type apo 
structure, which is consistent with the proposed water molecule interaction in which 
H293 forms a direct hydrogen bond with one of the trapped water molecules (W2). It is 
possible that this hydrogen bond restricts the atomic fluctuation of H293 (and its 
neighborhood by 35% projecting down to D290, E291), as they form the right-hand pillar 
of the multi-atomic bridge connecting the gatekeeper region with the top section of the 
α-helix of domain 2 of the ATP binding cleft (Fig. 4.3C). Our results also indicate that 
residue group 455-457, which forms the upper portion of the α-helix of domain 2, 
undergoes about 20% RMSF reduction, containing some of the strategically selected 
hotspot residues in the previously performed pairwise distance analysis. It also supports 
our model for water molecule interactions in the polar “hand-cuff”, since when the other 
trapped water molecule (W1) establishes a possible hydrogen bond with residue D454, 
the D454 – W1 – W2 – H293 bridge restricts the flexibility of the ATP binding cleft by a 
long range atomic cascade originating at the hinge mutation site. It is interesting to note 
that the ~25% SAS increase in the immediate vicinity of T324 and H293 shown in the 





since the two proposed residue pillars connecting to W1 and W2 may open up more area 
for water accessibility. 
 
4.5  Atomic interactions in the hinge region were altered by mutation 
To demonstrate that T324A mutation directly affected other residues in its immediate 
vicinity by forming chemical bonds or molecular interactions with particular atoms of the 
hinge, we defined a group of residues in the proximate neighborhood of the hinge within 
3.25 Å comparing the neighboring residues of the wild-type and T324A mutant NS3 
helicase apo structures. 
 
 By comparing three different seeds, we found two new residues unique to the T324A 
mutation in this group, namely residues H203 and V331, which were not present in the 
wild-type structure. To decide which one of the two is the best candidate to establish a 
direct atomic interaction with the hinge, we measured minimum distances for residue 
pairs 324-H203 and 324-V331 (Fig. 4.6) based on whole amino acid molecules. We 
found that residue V331 demonstrated a more drastic decrease in the minimum distance 
measurements, i.e., it is the closest to the hinge (on average) compared to residue H203. 
When we next assessed the minimum distance between all atoms of residue 324 and all 
atoms of residue V331, our results indicated that it reduces from about 5 Å to 2.5 Å, 






Figure 4.6 The hydrophobic interaction between A324 and V331 in the T324A mutant 
structure of NS3 helicase. This interaction was absent in the wild-type structure. The 
hydrophobic interaction potentially resulted in the structural rearrangement of residues in 
domain 2 (including S483 and D454 shown in the figure) to reduce the flexibility of the 
protein domains forming the ATP-binding cleft. 
 
 Next we zoomed down to the atomic level to identify the unique pair of participating 
atoms, where the true minimum distance occurred. Our results demonstrated that a 
particular atom pair of a hydrophobic interaction (A324:HB1 – V331:HG22) was the pair 
having the minimum distance through most of the trajectory for the mutant structure. So, 
we not only demonstrated the minimum distance decrease from 5 Å to 2.5 Å between 





interaction connections of A324 and V331, which only appeared with the hinge mutation. 
Based on these findings residue V331 may contribute to the flexibility modulation of the 
ATP binding cleft by directly interacting with the hinge. 
 
5. Unique interactions in DEAD-box helicase Mss116 
DEAD-box proteins have been implicated in almost every aspect of RNA metabolism, 
yet still very little is known about their function in vivo and how established in vitro 
activities correlate with their functions within cells. Although multiple models have been 
proposed for the ATPase or RNA unwinding functions of Mss116, their precise 
mechanism at the atomic details is still unclear. Up to now, no dynamics analysis has 
been reported evaluating the roles of the flexible linker connecting RecA-like domains 1 
and 2. In the present work, we investigate the behavior of the linker-domain 1/2 
interactions, using sequence analysis and molecular dynamics (MD) simulation, starting 
from a set of protein complexes. Sequence analysis and MD simulation could be 
powerful tools in identifying functional important residues for a specific protein family. 
In a recent published study, we have established a systematic approach of sequence 
analysis to identify conserved and unique residues of a protein family and applied this 
approach to reveal several important unique myosin VI residues [171]. In this study, our 
sequence analysis identifies residues that are conserved among Mss116 proteins and 





the flexible linker region of Mss116 reveals a set of residues involved in the modulation 
of the RecA-like domain motions during RNA crimping. 
 
5.1  Flexible linker is highly conserved among Mss116 proteins in diverse yeast 
species 
To compare the conservation of DEAD-box helicase Mss116 residues with residues 
of all other RNA helicases, we compared Mss116 reference sequences with other RNA 
helicases contained in the RNA Helicase Database [56]. First, we looked for Mss116 
protein sequences of different species using Protein-BLAST and aligned them with 
MAFFT and Clustal X. Nine Mss116 sequences from different species were found. 
 
Conservation analysis of DEAD-box helicase Mss116 was conducted by calculating 
the conservation scores in each residue column in the Mss116 alignment using ClustalX. 
We found a total of 133 100% conserved residues among the 664 residues of Mss116. As 
expected, most of the conserved residues were located within the RecA-like helicase core 
domains 1 and 2, which are known to catalyze RNA unwinding [61, 172] and play a 
critical role in helicase functions. In addition, Y537 was the only residue located within 
the CTE, probably contributing to RNA binding and stabilizing the structure of the 
helicase core [60]. Not surprisingly, no residues within the NTE or the basic tail were 





contributing to the Mss116 splicing function and has no role in the protein folding [61]. 
Finally, we identified a highly conserved loop in Mss116, the flexible linker connecting 
the two RecA-like domains and potentially controlling their relative motion to each other 
[61]. Although the flexible linker only contains nine residues, five of them, i.e. D332, 
N334, E335, P336 and H339 are 100% conserved within the Mss116 alignment, 
indicating the evolutionary and functional importance of this flexible linker. In Fig. 5.1, 
the first nine sequences show the sequence alignment of the highly conserved linker 
region among Mss116 of different species, while sequences 10 to 14 represent RNA 
helicase sequences demonstrating the diversity of this linker region in other RNA 
helicases (DEAD-box P3 of S. cerevisiae, RNA helicase DED1 of S. cerevisiae, 
DEAD-box p55 of H. sapiens, RNA helicase DDX39B of H. sapiens, and RNA helicase 






Figure 5.1 Sequence alignment of the flexible linker residues from a variety of RNA 
helicases. The first nine sequences are Mss116 proteins from different species, while the 
five remaining sequences represent RNA helicases other than Mss116. The residues in this 
flexible linker are highly conserved and distinct from the corresponding residues in other 
RNA helicases. 
 
5.2  Frequency analysis revealed residues conserved and specific for Mss116 
For the 100% conserved Mss116 residues, we further examined whether they are 
universally conserved among all RNA helicases or specific for Mss116. We examined 





acid of Mss116 in the corresponding aligned residue position. For example, N334 is 100% 
among Mss116. Examining the amino acids of all other RNA helicases in this same 
aligned column, we found none of them has an N at this residue position, indicating the 
amino acid Asn is not only 100% conserved among all Mss116 proteins but also specific 
for Mss116. We used three different groups of other RNA helicases to compare with the 
amino acids of Mss116 to illustrate how unique a specific amino acid is for Mss116 when 
compared with each of these groups. The smallest group of other RNA helicases contains 
68 DEAD-box RNA helicase sequences; the next group of other RNA helicases contain 
110 SF2 RNA helicase sequences, including all 68 DEAD-box RNA helicase sequences, 
and the largest group contain 126 SF1 and SF2 RNA helicase sequences including all 110 










Table 5.1 A rank of Mss116-specific residues that are 100% conserved in Mss116 and their 
corresponding amino acids are distinct from most of other RNA helicases (out of 68 
aligned sequences in the DEAD-box alignment, 110 aligned sequences in the SF2 




Counts in other 
SF1 and SF2 
RNA helicases 
Counts in other 
SF2 RNA 
helicases 
Counts in other 
DEAD-box 
RNA helicases 
N334 Linker 0 0 0 
P336 Linker 0 0 0 
D191 Motif Ia 1 1 1 
H339 Linker 2 1 1 
F258 
Near α8 and 
motif Ib 
2 2 2 
G428 Near motif V 4 4 4 
L129 Motif Q 4 4 4 
V181 
Near motifs Ia 
and Ib 
5 5 5 
Y537 α18 5 5 5 
Q450 
Near motifs IV 
and VI 
8 8 8 
T103 Near motif Q 10 9 8 
E335 Linker 12 11 10 
P139 Near motif Q 12 12 8 
P381 Motif IV 12 11 2 
M320 Near α11 13 13 13 
 
Table 5.1 shows top 15 of the 100% conserved residues whose amino acids are 
different from the amino acids of other RNA helicases in the same residue positions of 





uniqueness of these amino acids in DEAD-box helicase Mss116. Four highly conserved 
and unique residues were found in the flexible linker of Mss116 connecting the two 
RecA-like domains 1 and 2, including N334, E335, P336, and H339. Since the binding of 
ATP and RNA leads to a compact closed conformation state, in which these two domains 
extensively interact at the interface, the flexible linker might play a critical role in the 
RecA-like domain modulation as a hinge. Other Mss116-specific residues span in 
different regions as noted in Table 5.1: with 3 (V181, D191, F258) out of these 15 
residues residing in motifs Ia and Ib of domain 1; 3 residues (P381, G428, Q450) in 
motifs IV and V of domain 1; 3 residues (T103, P139, L129) in or near motif Q in the 
NTD; and residues Y537 and M320 near α18 and α11, respectively. The finding of these 
highly conserved and unique residues in motifs Ia, Ib, IV and V suggests their 
contribution to RNA binding, while the presence of motif Q indicates the critical 
involvement of NTD in ATP binding, which is required in hydrolysis. 
 
5.3  Structural examination identified unique interactions between the 
Mss116-specific flexible linker and the two RecA-like domains 
Fig. 5.2(a) illustrates the locations of the conserved and unique Mss116 residues 
in the crystal structure. N334, E335, P336 and H339 in the flexible linker are tightly close 
to each other in space.  Since these residues are located in the loop connecting 





which the two domains synchronously modulate RNA unwinding by using two wedges to 
act as a molecular crimper [64]. E335 locates at the flexible linker and it interacts with 
K95 at the tip of domain 1 through charge-charge interactions. The strong electrostatic 
interaction makes the flexible linker grab the tip of domain 1 tightly (Fig. 5.2(b)). The 
flexible linker also interacts with domain 2 as well. N334 and P336 interact with N496 






Figure 5.2 (a) Structure of Mss116 bound to ssRNA and ATP analog AMP-PNP, and the 
locations of Mss116-specific residues identified by our frequency analysis. Four 
Mss116-specific residues in the flexible linker, i.e. N334, E335, P336, H339 are clustered 
together. (b) Snapshot of Mss116 shows the atomic interactions between E335 of the 
flexible linker and K95 of domain 1. (c) Snapshot of Mss116 shows the atomic interactions 
between N334/P336 of the flexible linker and N496/I497 of domain 2. 
 
5.4  Conformational equilibrium analysis using MD simulation of the wild-type and 
mutant structures revealed unique interactions between the linker residue E335 
and domain 1 
To examine the role of those Mss116-specific residues in the flexible linker, we 
conducted a total of 300 ns MD simulation for a wild-type Mss116 structure (PDB ID: 
3I5X) and  four mutant models including N334A, N496A, E335A and N496A/I497A (3 
different seeds x 5 structures x 20 ns). The comparison of conformational equilibria 
between the wild-type structure and a mutant model illustrated how a corresponding 
mutation in the flexible linker may affect the relative movement of RecA-like domains 
upon ATP and RNA binding. Structural relaxation was monitored by analyzing the time 
revolution of the root mean square deviation (RMSD) of the frames with respect to the 





of the simulations within 20 ns. Thus, the initial crystal structure and the initial mutant 
models were well maintained during the simulation. 
 
The conserved and unique E335 in the flexible linker is positioned close to the 
RecA-like domain 1 of Mss116 and can potentially act as an interaction partner with 
domain 1 (Fig. 5.2(b)). For the wild-type structure, our MD simulation showed that E335 
interacts with residue K95 through a 20 ns trajectory, which is an energetically favorable 
contact between the flexible linker and domain 1. We then examined the conformational 
equilibria of the mutant model E335A and observed the loss of the contact between A335 
and K95. Loss of such interactions causes the detachment of the flexible linker from 
domain 1 and results in higher linker flexibility (Fig. 5.3(a), 5.3(b)). Trajectories of the 
backbone distances between residues K95 and 335 showed the difference between the 
wild-type and the E335A mutant structures (Fig. 5.3(c)), with a shifted mean distance and 
an altered standard deviation (Fig. 5.3(d)). In the wild-type simulation, the backbone 
distance between residues E335 and K95 stayed stable around an approximate mean 
value of 12 Å, whereas in the E335A simulation the backbone distance between residues 
A335 and K95 demonstrated a drastic increase at around 10 ns indicating the breakage of 
atomic interactions (Fig. 5.3(c)). This result indicates that E335 in the DEAD-box 
helicase Mss116 has the capability to position the RecA-like domain 1 to specific 










Figure 5.3 MD simulation showing the changes of conformational equilibria due to E335A 
mutation, perturbing the interactions between the conserved flexible linker and the 
RecA-like domain 1 of Mss116. (a), (b) Snapshots of the interactions between residue 335 
and K95 for the wild-type (blue) and the E335A mutant (red). The atomic interactions 
between E335 and K95 were lost when mutating to A335. (c) MD trajectories of the 
distances between the backbone atoms of residue 335 and K95. The trajectory of E335A is 
more distant than that of the wild-type structure, demonstrating a physical separation 
between the flexible linker and the RecA-like domain 1. (d) Histograms of (c) show a shift 
of the mean value and a change of the standard deviation (STD). 
 
5.5  Conformational equilibrium analysis identified interaction residues between 
the Mss116-specific linker and domain 2 
Our MD simulation results also demonstrated that several residues were clustered 
around the interaction site between the flexible linker and the tip of domain 2 of Mss116 
(Fig. 5.2(c)); namely residues N334 and P336 in the flexible linker, which form atomic 
interactions with residues N496 and I497 in domain 2. 
 
 First we tried single mutations of N334A and N496A. N334A mutation did not cause 
any conformational changes of the whole structure. One possible reason could be the 
unclear side chain position of N334 and also the atomic interaction analysis revealed it is 





interaction between linker loop and domain 2 still holds after 20ns simulation. We 
investigated the conformational equilibria of the N496A mutation and observed that 
P336-I497 interaction helps the domain 2 holds tightly with linker loop and longer 
simulation time is needed to see the effect of N496A single mutations. 
 
Due to the potential stability effect of mutating proline and the non-obvious results 
from single mutations, we decided instead to mutate their interaction sites N496 and I497 
together. We investigated the conformational equilibria of the N496A/I497A double 
mutation and observed the loss of atomic contacts between N334/P336 and N496/I497. 
Loss of such interactions caused the detachment of the flexible linker from domain 2 (Fig. 
5.4(a), 5.4(b)). Histogram of trajectories of the minimum backbone distances between 
residues pairs N334/P336 and 496/497 showed the difference between a wild-type 
structure and a double mutant construct, with a shifted mean distance and an altered 
standard deviation (Fig. 5.4(c)). In the wild-type simulation, the minimum backbone 
distance between residue pairs N334/P336 and N496/I497 stayed stable around an 
approximate mean value of 5 Å, whereas in the double mutant simulation, the minimum 
backbone distance between residue pairs N334/P336 and A496/A497 demonstrated a 
drastic increase to around 7 Å, indicating the breakage of atomic interactions. This result 





pair N496/I497 potentially play a critical role in modulating the conformational changes 







Figure 5.4 MD simulation showing the change of conformational equilibria due to a 
double mutation N496A/I497A, perturbing the interactions between the conserved flexible 
linker and the RecA-like domain 2 of Mss116. (a), (b) Snapshots of the interactions 
between residue pairs 496/497 and N334/P336 for the wild-type (blue) and the 
N496A/I497A mutant (red). The atomic interactions between N496/I497 and N334/P336 
were lost when mutating both of them to A. (c) Histograms of MD trajectories of minimum 
distances between the backbone atoms of residue pairs 496/497 and N334/P336 show a 
shift of the mean value and a change of the standard deviation (STD). 
5.6  Pairwise distance analysis revealed the mutations of E335A and N496A/I497A 
in the flexible linker increase the domain distances 
To examine how mutations of E335A and N496A/I497A influence the global 
conformation of the Mss116 structure, we selected three residue pairs as conformational 
markers to probe the relative positions of domains 1 and 2: (1) D301-K495 around the tip 
region of the two domains, (2) T307-A458 in the ATP binding site, and (3) I275-S539 in 
the RNA binding site (Fig. 5.5(a)). Histograms of distances between these three pairs 
show an increased mean and standard deviation in both mutant structures E335A and 
N496A/I497A when compared to the same pairs in the wild-type structure (Fig. 5.5(b), 
5.5(c), 5.5(d)). Thus, when introducing either a single mutation E335A or a double 
mutation N496A/I497A in the flexible linker connecting domains 1 and 2, the mutations 





or RNA binding [64]. The increased distance between two domains potentially weakens 
ATP and RNA binding and may affect the RNA crimping mechanism of Mss116 helicase. 
 
Figure 5.5 (a) Snapshot of Mss116 wild-type structure showing interfacial residue pairs 
for pairwise distance analysis. Residue pair D301-K495 is located on the top, T307-A458 
in the middle and I275-S539 at the bottom regions of the ATP and RNA-binding cleft. (b), 
(c) and (d) Histograms of minimum distance trajectories between the backbone atoms of 








The unique workflow of our algorithm from conservation analysis to computational 
mutations to computational simulation and virtual screening provides a framework to 
identify a manageable list of hotspot residues relating to the specific functions in myosin 
families, NS3 helicase and Mss116. 
 
We develop the sequence analysis method considering both conservation and 
uniqueness. Applying this proprietary algorithm, we identified residues specific for 
different myosin families/subfamilies based on the alignment of 1984 myosin sequences 
from 328 species. To the best of our knowledge, this is the first time such a complete 
sequence analysis has been conducted for all myosin families. 
 
Our sequence analysis of myosin families revealed several interesting features. For 
example, the SH1 domain is highly conserved in each myosin families and distinct from 
each other. The SH1 helix connects the motor domain and converter domain and it is 
believed to play a key role in the conformational changes that occur in the myosin head 
during force generation coupled to ATP hydrolysis. The strict conservation of this linker 
region among each myosin subfamily further underscores its functional importance. 
Mapping between existing mutation database and the myosin family specific residues 





residues and mutations in patients with HCM. We were also able to map between myosin 
VII specific residues and mutations in patients with USHB1. These mapping results 
validate our method. 
 
A significant portion of the family specific residues we found were neglect before. 
Many of them cluster in functionally important locations such as ATP binding site, actin 
binding site and the converter. And several highly unique residues were found in certain 
myosin families. Therefore, our studies provide a large number of testable hypotheses for 
further experimental examination.  
 
Myosin VI possesses unique structural arrangement and mechanochemical 
characteristics that are different from any other myosins. We dig into myosin VI using 
MD simulations and virtual screening in order to identify the relationship between 
myosin VI specific residues and specific functions. Our sequence analysis found that out 
of 30 myosin specific residues, 11 of them are either within or adjacent to the converter 
domain. A majority of these residues also show their uniqueness in myosin VI when 
taking the evolutionary similarity and physiochemical properties into consideration. The 
highly concentrated population of myosin VI-specific residues in the converter domain 
region illustrates the important roles of the converter domain in the unique features of 





of F763, F766, and M770 may play a role in the helix repositioning [141]. In addition, 
several converter domain residues have been suggested for possible roles in structural 
interactions, including L726, A737, L738, A741, and L742. Our conservation analysis 
indeed showed F763, F766, and M770 are conserved and unique for myosin VI, and we 
suggested additional residues potentially important in this region, including M701, Y715, 
L729, F734, and K762. Our MD simulation further demonstrated that F763 potentially 
plays an important role in bridging the converter domain and the motor domain. The 
mutant F763L destroyed the interaction between these two domains. All these residues 
and other myosin VI-specific residues need to be further investigated to determine which 
roles in myosin VI functions each of these residues play, such as to drive a large rotation 
angle of the converter domain, to facilitate the structural rearrangement of the converter 
domain, or to position the unique insert II toward the reverse direction.  
 
Besides the converter domain, we also found myosin VI-specific residues close to the 
actin binding site, possibly regulating the actin binding for its high duty ratio. One of the 
myosin VI-specific residues is in the ATP binding pocket, potentially controlling the 
ligand binding and release for the specific kinetics of myosin VI. The other two myosin 
VI-specific residues, P444 and F445, are located in a region that is far from the actin 
binding site, the ATP binding site, and the converter domain. These two residues are in a 





cardiomyopathy loop, and the fifth β-strand of the central β-sheet, a strand followed by 
the energy transducing switch II. This loop was named the HO linker [173], and very 
limited studies have been reported for this linker [174]. It is possible that this linker plays 
an essential role in communicating the ATP binding and the actin binding for their 
coupling in myosin VI, although other possible roles cannot be ruled out. The 
identification of these two residues in the HO linker demonstrates the merit of this 
conservation analysis, because it pinpoints potentially important residues that would 
likely be ignored when only considering residues adjacent to all the functional sites. 
 
Besides myosin families, we expanded our study to other molecular motors such as 
NS3helix and DEAD box protein Mss116. 
 
We have investigated the dynamic mechanism of HCV NS3 helicase ATP binding 
cleft flexibility modulation. In our histogram analysis of pairwise distances between 
residues in domains 1 and 2, we showed a drastically reduced standard deviation of 
separation between the two domains in the mutant structure. This indicates that mutation 
of the hinge residue T324 to A triggers a flexibility decrease of the ATP binding cleft. We 
showed that two new water molecules were recruited in the hinge vicinity, which directly 
interact with residues H293 and D454 via hydrogen bonds. We further hypothesized that 





hinge region to the α-helix of domain 2, and thus restrict the flexibility of the ATP 
binding cleft by a “hand-cuffing” effect. Our analysis identified a small set of residues, 
including residue H293 and S483, with significantly increased SAS when the hinge 
residue was mutated. We also found a set of residue groups with large RMSF decrease, in 
the immediate neighborhood of the hinge including A323 to S328; residues such as S483, 
which probably coordinate the immobilization of the two new water molecules; residues 
involved in the atomic connection between the hinge and the α-helix of domain 2; the 
left-hand arm of ATP binding cleft, including the arginine finger R467; and residues close 
to the Walker B motif, including residue H293. Both of our SAS and RMSF results 
supported our water interaction model of a multi-atomic bridge, thus providing a better 
understanding of the underlying molecular mechanism of the ATP binding cleft flexibility 
modulation. Finally, we pinpointed a direct atomic interaction between hinge residue 
A324 and V331, providing suggestions for future experiments to decipher the atomic 
interaction cascade of flexibility control of the ATP binding cleft. 
 
 The dynamic flexibility change of the ATP binding cleft can possibly be explained by 
the following water molecule interactions. When T324 is mutated to A, it loses an OH 
group. This 3D structural change around the hinge residue may open up more space and 
allow the immobilization of two water molecules (W1 and W2) into a newly formed 





keeper residue H293 may establish a hydrogen bond (1.70 Å) with W2, while D454 – 
located at the top region of the same α-helix on which the domain 2 hotspot residues of 
the ATP binding cleft reside – can also form a hydrogen bond (1.65 Å) with W1. 
Furthermore, W1 and W2 are also connected by a possible hydrogen bond (1.71 Å) 
completing an atomic bridge containing 4 molecules (D454 – W1 – W2 – H293) linking 
the hinge region to the α-helix of domain 2, which is part of the highly conserved 
arginine finger critical for catalysis. We propose that this intricate atomic cascade causes 
a “hand-cuffing” polar effect, such that the dynamic nature of hinge mechanism becomes 
more rigid, restricting flexibility of domains 1 and 2 for opening and closing of the ATP 
binding cleft. 
 
 Even though residue S483 is not close enough (2.49 Å) to form a direct hydrogen 
bond with W2, we hypothesize that it can guide the two water molecules into the newly 
formed trapping pocket by polar-polar interaction of its side chain. It is also interesting to 
note that nonpolar residues G484, A455 and V456 do not possess a dipole moment, 
because such molecules are insoluble in water. These hydrophobic residues do not form 
hydrogen bonds with water molecules (W1 and W2), but can force them into a rigid cage 
of hydrogen-bonded residues around it. Water molecules are normally in constant motion, 
and the formation of such cages restricts their motion. The synergistic effect of these 





for water molecule immobilization close to the hinge region. 
 
 This proposed water molecule interaction was supported by the results of our RMSF 
analysis, since we observed a drastic 57% RMSF drop of residue S483 with an averaged 
40% decrease in the residue cluster that is claimed to be responsible for the 3D guidance of 
water molecules into this pocket. Our results indicate that the polar-polar interaction 
between W1 and S483 restricts the atomic fluctuation of this residue, which also influences 
the RMSF of the neighboring residues P482 and G484 as shown in a previous section. 
Similarly, we found a significant 30% and 16% RMSF decrease of residues G327 and S328 
respectively, with an averaged 33% decrease in the residue group that may be responsible 
for the atomic rearrangement to form the water trapping pocket. P326 is a member of this 
group and may indirectly promote water molecule positioning by opening up more 
solvent accessible surface. Its RMSF decrease clearly demonstrated that this nonpolar 
region can form one of the sides of the rigid water box. 
 
 In a previous study [175] that examined functions of conserved helicase motifs and 
their mechanistic role in ATP-dependent duplex oligonucleotide separation, it was shown 
that residues within Walker B motifs of SF-2 helicases, residue H293 in particular for 
HCV, interact with the conserved glutamine of motif VI in domain 2. It was also pointed 





arginine residues to ligate ATP, which is only plausible because of the high interdomain 
flexibility of the protein. Our RMSF analysis is consistent with this observation, since the 
α-helix of domain 2 involved in the coupling of ATPase to helicase undergoes a drastic 33% 
RMSF decrease. This domain contains one of the strategically selected hotspot residues 
in our pairwise distance analysis, namely residue Q460 with 35% RMSF drop compared 
to the wild-type NS3 helicase apo structure. Furthermore, the α-helix of domain 2, which 
forms the left-hand region of ATP binding cleft and contains R464 and R467 hotspot 
residues used in the pairwise distance analysis, undergoes a significant 25% RMSF 
decrease. The average distance between the mutated hinge residue A324 and the spatially 
distant residues (R458, S459, Q460, R464 and R467) was found to be in the range of 
10-17 Å with a mean distance of 13.37 Å. These results indicate that the T324A mutation 
did not only influence the immediate neighborhood of the hinge by new water 
recruitment, but other spatially distant residues were also affected, demonstrating a 
long-range coupling mechanism that can transmit signals between distant sites resulting 
in the blocking of ATPase activity by restricting interdomain flexibility. 
 
 Consistent with our previous SAS and RMSF analysis, we found that residue V331 
establishes a possible hydrophobic interaction with A324, and thus forms a loop 
containing residue cluster 325-328. We propose a mechanism in which residue A324 





promoting a regional flexibility decrease which is reflected by the 30% and 16% RMSF 
reductions of residues G327 and S328 respectively, with an averaged 33% decrease in the 
residue group that orchestrates the water trapping pocket formation. This atomic linkage 
can be further explained by the RMSF reduction in the residue group which possibly 
forms one of the sides of the hydrophobic water box caging W1 and W2 into the newly 
formed pocket. 
 
 This analysis predicts a long-range atomic network effecting residues located in 
domain 1 of the ATP binding cleft, which have not been explored with computational 
studies thus far. This provides targets for future MD simulations to evaluate the changes in 
this microenvironment. Also, our hypothesis that residue A324 grabs onto V331 and pulls 
that protein region close to the hinge after mutation, opens up further possibilities for 
domain 2 and residue V331 to interact. We suspect that the RMSF decrease of residues 
454-457 is not only due to the water bridge, but also the atomic interaction between domain 
2 and V331. This hypothesis calls for future evaluation to elucidate the exact relationship 
between ATPase activity decrease and 3D structural changes. 
 
Mss116 is a mitochondrial DEAD-box RNA helicase essential for efficient group 
I and group II intron splicing and for activation of mRNA translation [51, 176-178]. We 





important for its RNA-duplex recognition and unwinding characteristics. By first 
identifying highly conserved Mss116 residues and then systematically comparing them 
with the residues of other RNA helicases in the corresponding alignment positions, we 
found a set of Mss116-specific residues that are distinct from residues in other RNA 
helicases. Many of these conserved residues were found within the ATP and RNA binding 
domains; and have been excessively studied by genetic and structural analyses [61, 
64-65]. In addition, our methods also revealed four highly conserved Mss116-specific 
residues within the flexible linker connecting RecA-like domains 1 and 2, i.e. N334, 
E335, P336 and H339. Residue interactions E355-K95 and N334/P336-N496/I497 were 
found to be strong and very stable in the wild-type structure, while mutations of E335A 
and N496A/I497A abolish the atomic interactions between the flexible linker and the top 
portions of the two domains, revealing Mss116-specific interactions between this flexible 
linker and both RecA-like domains. Both E335A and N496A/I497A residue mutations 
cause the two domains to significantly separate from each other.  
 
Previous studies described models of RNA-strand separation by DEAD-box 
proteins [64-65]. They demonstrated that prior ATP and duplex RNA binding, the helicase 
core is in an open conformation state. Binding of both substrates triggers a 
conformational change leading to a so-called pre-wound (partially closed) state. This is 





one RNA strand is crimped due to the RNA strand and domains 1 and 2 interface 
interactions in the binding cleft. This model suggests that the synchronous interplay of 
the flexible linker of Mss116 and DEAD-box protein motifs that function in RNA or ATP 
binding or interdomain interactions [179] might play a critical structural role in the 
duplex RNA recognition and unwinding of DEAD-box proteins.  
 
The flexible linker of Mss116, however, is highly distinct from the flexible linker 
of other RNA helicases in terms of its sequence. The 100% conserved N334-E335-P336, 
which are drastically different from the aligned residues of other RNA helicases, 
challenge our understanding of how this loop can do for a helicase. Usually the flexible 
linker is thought of as a hinge to allow the bending motion between two RecA-like 
domains. In our previous computational study that examined the mechanism of flexibility 
control for ATP access of NS3 helicase [180], a residue within the flexible hinge 
connecting domains 1 and 2 of the ATP-binding cleft was shown to play a critical role in 
the atomic coordination of the cleft opening. It was also pointed out that a series of cleft 
residues, from the hinge residue to residues in domains 1 and 2 control the 
opening/closing of the ATP-binding cleft via an atomic interaction cascade. For Mss116, 
however, we found that one of these three conserved, Mss116-specific, and consecutive 
residues form charge-charge interactions with domain 1, while two others strongly 





the residue positions of N334 and P336 of Mss116, respectively, while all 9 Mss116 
sequences have N and P in these two positions. This finding shows drastically strong 
uniqueness of these flexible linker residues for Mss116, indicating irreplaceable functions 
of these residues.  
 
Our conformational equilibrium studies by short MD simulation runs 
demonstrated quick losses of interactions between the flexible linker and the two 
RecA-like domains when mutating those conserved and unique residues, at the time scale 
of 10 ns. Losses of these interactions in such a short time indicate the significance of 
these interactions in holding the structure, because a mutational effect usually cannot be 
observed at a longer time scale. It is possible that the interactions of E335-K95 and 
N334/P336-N496/I497 provide forces to bend the two RecA-like domains stronger than 
other RNA helicases such that these forces are enough to distort RNA duplexes instead of 
one RNA strand for other DEAD-box helicases and other RNA helicases. The additional 
interactions provided by the conserved and unique residues in the flexible linker of 
Mss116 may serve as extra attached strings on both sides to convert the ATP binding 
energy more effectively to bend RNA. Based on our results, we predict that when 
mutating any of these conserved and unique flexible linker residues experimentally, the 
RNA bending capability will be compromised and the functions such as slicing introns 





these flexible linker residues are by detailed biochemical and kinetic studies.  
 
Our studies were based on a fundamental assumption that all Mss116 proteins possess 
residues that are responsible for tasks specific and unique for Mss116 proteins across 
species. The analysis yields valuable and important new information about the structure 
of Mss116 especially emphasizing the flexible linker region acting as a hinge connecting 
domains 1 and 2. There are also a few limitations to be noted when using this sequence 
analysis method. Our choices of RNA helicases alignments and scoring functions 
represent a limited approach to obtain Mss116-specific residues. More rigorous selections 
of approaches may provide less biased outcomes. Also, the requirement of 100% 
conservation may be too strict to eliminate some important residues. Therefore, some 
flexibility in the conservation may be needed in the future. On the other hand, the 
requirement of 100% conservation did facilitate the identification of a small set of 
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